Exact Mass: 285.0646

Exact Mass Matches: 285.0646

Found 468 metabolites which its exact mass value is equals to given mass value 285.0646, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Letrozole

Letrozole, Pharmaceutical Secondary Standard; Certified Reference Material

C17H11N5 (285.1014)


Letrozole is a member of triazoles and a nitrile. It has a role as an antineoplastic agent and an EC 1.14.14.14 (aromatase) inhibitor. Letrozole, or CGS 20267, is an oral non-steroidal type II aromatase inhibitor first described in the literature in 1990. It is a third generation aromatase inhibitor like [exemestane] and [anastrozole], meaning it does not significantly affect cortisol, aldosterone, and thyroxine. Letrozole was granted FDA approval on 25 July 1997. Letrozole is an Aromatase Inhibitor. The mechanism of action of letrozole is as an Aromatase Inhibitor. Letrozole is a nonsteroidal inhibitor of aromatase which effectively blocks estrogen synthesis in postmenopausal women and is used as therapy of estrogen receptor positive breast cancer, usually after resection and after failure of tamoxifen. Letrozole has been associated with a low rate of serum enzyme elevations during therapy and rare instances of clinically apparent liver injury. Letrozole is a nonsteroidal inhibitor of estrogen synthesis with antineoplastic activity. As a third-generation aromatase inhibitor, letrozole selectively and reversibly inhibits aromatase, which may result in growth inhibition of estrogen-dependent breast cancer cells. Aromatase, a cytochrome P-450 enzyme localized to the endoplasmic reticulum of the cell and found in many tissues including those of the premenopausal ovary, liver, and breast, catalyzes the aromatization of androstenedione and testosterone into estrone and estradiol, the final step in estrogen biosynthesis. Letrozole (INN, trade name Femara®) is an oral non-steroidal aromatase inhibitor that has been introduced for the adjuvant treatment of hormonally-responsive breast cancer. Estrogens are produced by the conversion of androgens through the activity of the aromatase enzyme. Letrozole blocks production of estrogens in this way by competitive, reversible binding to the heme of its cytochrome P450 unit. The action is specific, and letrozole does not reduce production of mineralo- or corticosteroids. In contrast, the antiestrogenic action of tamoxifen, the major medical therapy prior to the arrival of aromatase inhibitors, is due to its interfering with the estrogen receptor, rather than inhibiting estrogen production. Letrozole is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women. Side effects include signs and symptoms of hypoestrogenism. There is concern that long term use may lead to osteoporosis, which is why prescriptions of Letrozole are often accompanied by prescriptions of osteoporosis-fighting medication such as Fosamax. Letrozole has shown to reduce estrogen levels by 98 percent while raising testosterone levels. The anti-estrogen action of letrozole is preferred by athletes and bodybuilders for use during a steroid cycle to reduce bloating due to excess water retention and prevent the formation of gynecomastia related breast tissue that is a side effect of some anabolic steroids. Usage above 2.5 mg/day is known to potentially temporarily kill sex drive. Above 5mg/day for extended periods may cause kidney problems. Letrozole has also been shown to delay the fusing of the growth plates in adolescents. This may boost the effectiveness of growth hormone, and thus Letrozole is used to treat adolescents and children with short stature. A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women. See also: Letrozole; ribociclib succinate (component of). Letrozole (INN, trade name Femara) is an oral non-steroidal aromatase inhibitor that has been introduced for the adjuvant treatment of hormonally-responsive breast cancer L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BG - Aromatase inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D047072 - Aromatase Inhibitors C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist D000970 - Antineoplastic Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 3585 Letrozole (CGS 20267) is a potent, selective, reversible and orally active non-steroidal inhibitor of aromatase, with an IC50 of 11.5 nM. Letrozole selective inhibits estrogen biosynthesis, and can be used for the research of breast cancer[1][2][3].

   

Probenecid

4-((Dipropylamino)sulphonyl)benzoic acid

C13H19NO4S (285.1035)


The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy. [PubChem] CONFIDENCE standard compound; INTERNAL_ID 208; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4243; ORIGINAL_PRECURSOR_SCAN_NO 4241 CONFIDENCE standard compound; INTERNAL_ID 208; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4209; ORIGINAL_PRECURSOR_SCAN_NO 4206 CONFIDENCE standard compound; INTERNAL_ID 208; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4239; ORIGINAL_PRECURSOR_SCAN_NO 4234 ORIGINAL_PRECURSOR_SCAN_NO 4241; CONFIDENCE standard compound; INTERNAL_ID 208; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4243 CONFIDENCE standard compound; INTERNAL_ID 208; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4238; ORIGINAL_PRECURSOR_SCAN_NO 4234 CONFIDENCE standard compound; INTERNAL_ID 208; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4245; ORIGINAL_PRECURSOR_SCAN_NO 4243 CONFIDENCE standard compound; INTERNAL_ID 208; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4200; ORIGINAL_PRECURSOR_SCAN_NO 4198 M - Musculo-skeletal system > M04 - Antigout preparations > M04A - Antigout preparations > M04AB - Preparations increasing uric acid excretion D018501 - Antirheumatic Agents > D006074 - Gout Suppressants > D014528 - Uricosuric Agents C26170 - Protective Agent > C921 - Uricosuric Agent D010592 - Pharmaceutic Aids

   

5-Amino-4-chloro-2-(5-hydroxymuconoyl)-3(2H)-pyridazinone

5-Amino-4-chloro-2-(5-hydroxymuconoyl)-3(2H)-pyridazinone; 5-Amino-4-chloro-2-(2-hydroxymuconoyl)-3(2H)-pyridazinone

C10H8ClN3O5 (285.0152)


   

Riccionidin A

Riccionidin A

C15H9O6+ (285.0399)


   

Buchananine

ZINC00898995

C12H15NO7 (285.0848)


   

Arborinine

9(10H)-Acridinone, 1-hydroxy-2,3-dimethoxy-10-methyl- (9ci)

C16H15NO4 (285.1001)


Arborinine is found in herbs and spices. Arborinine is an alkaloid from Ruta graveolens (rue

   
   

MFCD00049038

5-Deoxy-5-chloroadenosine

C10H12ClN5O3 (285.0629)


   

Fludarabine

Fludarabine Base

C10H12FN5O4 (285.0873)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BB - Purine analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2150 - Ribonucleotide Reductase Inhibitor D000970 - Antineoplastic Agents Fludarabine (NSC 118218) is a DNA synthesis inhibitor and a fluorinated purine analogue with antineoplastic activity in lymphoproliferative malignancies. Fludarabine inhibits the cytokine-induced activation of STAT1 and STAT1-dependent gene transcription in normal resting or activated lymphocytes[1][2][3][4].

   

Vidarabine monohydrate

Vidarabine monohydrate

C10H15N5O5 (285.1073)


D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent D009676 - Noxae > D000963 - Antimetabolites Vidarabine monohydrate is an adenine arabinoside. Vidarabine monohydrate an antiviral agent which is active against herpes simplex viruses (HSV) and varicella zoster viruses[1].

   

N-Acetylcytidine

N(4)-acetylcytidine

C11H15N3O6 (285.0961)


Cytidine in which one of the exocyclic amino hydrogens is substituted by an acetyl group. N4-Acetylcytidine is an endogenous metabolite. N4-Acetylcytidine is an endogenous metabolite.

   

4-nitrophenyl-alpha-l-fucopyranoside

p-Nitrophenyl 6-deoxy-alpha-L-galactopyranoside

C12H15NO7 (285.0848)


   

N4-Acetylcytidine

N-{1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-2-oxo-1,2-dihydropyrimidin-4-yl}acetamide

C11H15N3O6 (285.0961)


N4-Acetylcytidine is a modified nucleoside. N4-acetylcytidine is an endogenous urinary nucleoside product of the degradation of transfer ribonucleic acid (tRNA); urinary nucleosides are biological markers for patients with colorectal cancer. tRNA has been shown to be excreted in abnormal amounts in the urine of cancer patients. tRNA from neoplastic tissue had a much more rapid turnover rate than the tRNA from the corresponding normal tissue. Evidence indicates that methylation of tRNA occurs only after synthesis of the intact macromolecule. Because there are no specific enzyme systems to incorporate the modified nucleosides into the macromolecular nucleic acid, these nucleosides once released in the process of tRNA turnover cannot be reutilized, nor are they further degraded, but are excreted in urine. (PMID: 15991285, 3506820) [HMDB] N4-Acetylcytidine is a modified nucleoside. N4-acetylcytidine is an endogenous urinary nucleoside product of the degradation of transfer ribonucleic acid (tRNA); urinary nucleosides are biological markers for patients with colorectal cancer. tRNA has been shown to be excreted in abnormal amounts in the urine of cancer patients. tRNA from neoplastic tissue had a much more rapid turnover rate than the tRNA from the corresponding normal tissue. Evidence indicates that methylation of tRNA occurs only after synthesis of the intact macromolecule. Because there are no specific enzyme systems to incorporate the modified nucleosides into the macromolecular nucleic acid, these nucleosides once released in the process of tRNA turnover cannot be reutilized, nor are they further degraded, but are excreted in urine. (PMID: 15991285, 3506820). N4-Acetylcytidine is an endogenous metabolite. N4-Acetylcytidine is an endogenous metabolite.

   

Cladribine

(2R,3S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol

C10H12ClN5O3 (285.0629)


Cladribine is only found in individuals that have used or taken this drug. It is an antineoplastic agent used in the treatment of lymphoproliferative diseases including hairy-cell leukemia. [PubChem]Cladribine is structurally related to fludarabine and pentostatin but has a different mechanism of action. Although the exact mechanism of action has not been fully determined, evidence shows that cladribine is phosphorylated by deoxycytidine kinase to the nucleotidecladribine triphosphate (CdATP; 2-chloro-2′-deoxyadenosine 5′-triphosphate), which accumulates and is incorporated into DNA in cells such as lymphocytes that contain high levels of deoxycytidine kinase and low levels of deoxynucleotidase, resulting in DNA strand breakage and inhibition of DNA synthesis and repair. High levels of CdATP also appear to inhibit ribonucleotide reductase, which leads to an imbalance in triphosphorylated deoxynucleotide (dNTP) pools and subsequent DNA strand breaks, inhibition of DNA synthesis and repair, nicotinamide adenine dinucleotide (NAD) and ATP depletion, and cell death. Unlike other antimetabolite drugs, cladribine has cytotoxic effects on resting as well as proliferating lymphocytes. However, it does cause cells to accumulate at the G1/S phase junction, suggesting that cytotoxicity is associated with events critical to cell entry into S phase. It also binds purine nucleoside phosphorylase (PNP), however no relationship between this binding and a mechanism of action has been established. L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants > L04AA - Selective immunosuppressants L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BB - Purine analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents C471 - Enzyme Inhibitor > C2157 - Adenosine Deaminase Inhibitor C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent D000970 - Antineoplastic Agents Cladribine (2-Chloro-2′-deoxyadenosine), a purine nucleoside analog, is an orally active adenosine deaminase inhibitor. Cladribine functions as an inhibitor of DNA synthesis to block the repair of the damaged DNA. Cladribine can inhibit DNA methylation. Cladribine has anti-lymphoma activity. Cladribine can be used for the research of several hematologic malignancies and multiple sclerosis[1][2].

   

7-Aminoclonazepam

7-amino-5-(2-chlorophenyl)-3H-1,4-benzodiazepin-2-ol

C15H12ClN3O (285.0669)


7-aminoclonazepam belongs to the family of Benzodiazepines. These are organic compounds containing a benzene ring fused to either isomers of diazepine(unsaturated seven-member heterocycle with two nitrogen atoms replacing two carbon atoms).

   

Faropenem

(+)-(5R,6S)-6-((1R)-1-Hydroxyethyl)-7-oxo-3-((2R)-tetrahydro-2-furyl)-4-thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid

C12H15NO5S (285.0671)


Faropenem is an orally active beta-lactam antibiotic belonging to the penem group. It is resistant to some forms of extended-spectrum beta-lactamase. It is available for oral use. Faropenem was developed by Daiichi Asubio Pharma, which markets it in two forms. The sodium salt faropenem sodium, available under the trade name Farom, has been marketed in Japan since 1997. (CID 636379 from PubChem) The prodrug form faropenem medoxomil (also known as faropenem daloxate) has been licensed from Daiichi Asubio Pharma by Replidyne, which plans to market it in conjunction with Forest Pharmaceuticals. The trade name proposed for the product was Orapem, but company officials recently announced this name was rejected by the FDA.

   

Asenapine

17-chloro-4-methyl-13-oxa-4-azatetracyclo[12.4.0.0^{2,6}.0^{7,12}]octadeca-1(14),7,9,11,15,17-hexaene

C17H16ClNO (285.092)


   

2,5-Dioxopyrrolidin-1-yl quinolin-6-ylcarbamate

2,5-dioxopyrrolidin-1-yl N-(quinolin-6-yl)carbamate

C14H11N3O4 (285.075)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents

   

2-Chloro-3'-deoxyadenosine

2-(6-amino-2-chloro-9H-purin-9-yl)-5-(hydroxymethyl)oxolan-3-ol

C10H12ClN5O3 (285.0629)


   

2-Fluoroadenosine

2-(6-amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C10H12FN5O4 (285.0873)


   

3-Carbamyl-(3'-picolyl)-4-methoxy-1-benzamide

6-methoxy-N1-[(pyridin-3-yl)methyl]benzene-1,3-dicarboxamide

C15H15N3O3 (285.1113)


   

5-(4-Fluorophenyl)-3-(3-nitrophenyl)-1,2,4-oxadiazole

5-(4-Fluorophenyl)-3-(3-nitrophenyl)-1,2,4-oxadiazole

C14H8FN3O3 (285.055)


   

arabinosyl-2-fluoroadenine

2-(6-amino-2-fluoro-7H-purin-8-yl)oxane-3,4,5-triol

C10H12FN5O4 (285.0873)


   

9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine

9-chloro-2-(furan-2-yl)-[1,2,4]triazolo[1,5-c]quinazolin-5-amine

C13H8ClN5O (285.0417)


   

4-(2-Methoxyphenyl)-2-((5-methyl-1H-imidazol-4-yl)methyl)thiazole

4-(2-methoxyphenyl)-2-[(5-methyl-1H-imidazol-4-yl)methyl]-1,3-thiazole

C15H15N3OS (285.0936)


   

Flunoxaprofen

2-[2-(4-fluorophenyl)-1,3-benzoxazol-5-yl]propanoic acid

C16H12FNO3 (285.0801)


   

N-Benzoyl-L-tyrosine

2-{[hydroxy(phenyl)methylidene]amino}-3-(4-hydroxyphenyl)propanoate

C16H15NO4 (285.1001)


   

Nifuratel

5-[(Methylsulphanyl)methyl]-3-{[(5-nitrofuran-2-yl)methylidene]amino}-1,3-oxazolidin-2-one

C10H11N3O5S (285.0419)


   

2-Chloro-9-(2-deoxy-beta-D-arabinofuranosyl)adenine

5-(6-amino-2-chloro-9H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol

C10H12ClN5O3 (285.0629)


   

2-Amino-9-(6-oxo-1H-purin-9-yl)-1H-purin-6-one

2-Amino-9-(6-oxo-1H-purin-9-yl)-1H-purin-6-one

C10H7N9O2 (285.0723)


   

3H-1,4-Benzodiazepin-2-amine, 7-chloro-5-phenyl-, 4-oxide

7-chloro-2-imino-5-phenyl-3,4-dihydro-2H-1,4-benzodiazepin-4-ol

C15H12ClN3O (285.0669)


   

Theasaponin E3

(2S)-3-hydroxy-2-(2-nitrophenyl)-1,2,3,4-tetrahydroquinazolin-4-one

C14H11N3O4 (285.075)


Theasaponin e3 is a member of the class of compounds known as quinazolines. Quinazolines are compounds containing a quinazoline moiety, which is made up of two fused six-member aromatic rings, a benzene ring and a pyrimidine ring. Theasaponin e3 is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Theasaponin e3 can be found in tea, which makes theasaponin e3 a potential biomarker for the consumption of this food product.

   

taxol side chain

(2R,3S)-3-(Benzoylamino)-2-hydroxy-3-phenylpropionic acid; (2R,3S)-N-Benzoyl-3-phenylisoserine; N-Benzoyl-(2R,3S)-3-phenylisoserine; Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, (alphaR,betaS)-; Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, [R-(R*,S*)]-; Taxol side chain acid

C16H15NO4 (285.1001)


N-Benzoyl-(2R,3S)-3-phenylisoserine is a Taxol C-13 Side Chain and crucial for the strong antitumor activity of Taxol[1].

   
   
   

Toddaliopsin A

Toddaliopsin A

C16H15NO4 (285.1001)


   

N-Formylismine

N-Formylismine

C16H15NO4 (285.1001)


   

Carbazomycin F

Carbazomycin F

C16H15NO4 (285.1001)


   
   

Riccionidin A

Chromeno [ 3,2-b ] [ 1 ] benzoxol-5-ium-2,3,6,8-tetrol

C15H9O6 (285.0399)


   
   
   
   

Maybridge1_001794

Maybridge1_001794

C13H19NO4S (285.1035)


   
   

N-glucosylnicotinate

N-glucosylnicotinate

C12H15NO7 (285.0848)


   

CHEMBL1095074

CHEMBL1095074

C16H15NO4 (285.1001)


   

1-(3,4-dichlorophenyl)-6,6-dimethyl-1,3,5-triazine-2,4-diamine

1-(3,4-dichlorophenyl)-6,6-dimethyl-1,3,5-triazine-2,4-diamine

C11H13Cl2N5 (285.0548)


   

aleurodiscoester

aleurodiscoester

C12H15NO7 (285.0848)


   

CHEMBL1094823

CHEMBL1094823

C16H15NO4 (285.1001)


   

O1-(3-amino-phenyl)-beta-D-glucopyranuronic acid|O1-(3-Amino-phenyl)-beta-D-glucopyranuronsaeure

O1-(3-amino-phenyl)-beta-D-glucopyranuronic acid|O1-(3-Amino-phenyl)-beta-D-glucopyranuronsaeure

C12H15NO7 (285.0848)


   

8-isopropenyl-10-methyl-7,10-dihydro-8H-[1,3]dioxolo[4,5-h]furo[2,3-b]quinolin-6-one|Ptelefolidon|Ptelefolidone

8-isopropenyl-10-methyl-7,10-dihydro-8H-[1,3]dioxolo[4,5-h]furo[2,3-b]quinolin-6-one|Ptelefolidon|Ptelefolidone

C16H15NO4 (285.1001)


   
   

4-Aminophenyl-beta-D-glucuronide

4-Aminophenyl-beta-D-glucuronide

C12H15NO7 (285.0848)


   

MEGxm0_000317

MEGxm0_000317

C16H15NO4 (285.1001)


   

demethylmasonine

demethylmasonine

C16H15NO4 (285.1001)


   

Bezerramycin A

Bezerramycin A

C14H11N3O4 (285.075)


   
   

(E)-2-[(3-Indole)cyanomethylene]-3-indolinone

(E)-2-[(3-Indole)cyanomethylene]-3-indolinone

C18H11N3O (285.0902)


   

3-hydroxy-2,4-dimethoxy-10-methyl-10H-acridin-9-one|3-hydroxy-2,4-dimethoxy-10-methyl-9-acridinone

3-hydroxy-2,4-dimethoxy-10-methyl-10H-acridin-9-one|3-hydroxy-2,4-dimethoxy-10-methyl-9-acridinone

C16H15NO4 (285.1001)


   

SCHEMBL21629440

SCHEMBL21629440

C16H15NO4 (285.1001)


   

1-Hydroxy-3,4-dimethoxy-10-methylacridan-9-one

1-Hydroxy-3,4-dimethoxy-10-methylacridan-9-one

C16H15NO4 (285.1001)


   

4-hydroxyphenethyl 3-oxo-2,3-dihydro-1H-pyrrolizine-2-carboxylate

4-hydroxyphenethyl 3-oxo-2,3-dihydro-1H-pyrrolizine-2-carboxylate

C16H15NO4 (285.1001)


   
   

aflaquinolone E

aflaquinolone E

C16H15NO4 (285.1001)


   

Actinomycinol

Actinomycinol

C15H11NO5 (285.0637)


   
   

1-Hydroxy-2,3-dimethoxy-10-methylacridan-9-on

1-Hydroxy-2,3-dimethoxy-10-methylacridan-9-on

C16H15NO4 (285.1001)


   

4,9-anhydro-11-deoxyTTX

4,9-anhydro-11-deoxyTTX

C11H15N3O6 (285.0961)


   

4a,N-didehydronoraugustamine

4a,N-didehydronoraugustamine

C16H15NO4 (285.1001)


   

7,8-Dehydrorutaecarpine

7,8-Dehydrorutaecarpine

C18H11N3O (285.0902)


   

1-Hydroxy-3,5-dimethoxy-10-methylacridine-9(10H)-one

1-Hydroxy-3,5-dimethoxy-10-methylacridine-9(10H)-one

C16H15NO4 (285.1001)


   

2-Aminophenyl b-D-glucuronide HCl

2-Aminophenyl b-D-glucuronide HCl

C12H15NO7 (285.0848)


   

Nicotinic acid-hexoside

Nicotinic acid-hexoside

C12H15NO7 (285.0848)


   
   

Cladribine

Cladribine

C10H12ClN5O3 (285.0629)


L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants > L04AA - Selective immunosuppressants L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BB - Purine analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents C471 - Enzyme Inhibitor > C2157 - Adenosine Deaminase Inhibitor C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent D000970 - Antineoplastic Agents CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2617; ORIGINAL_PRECURSOR_SCAN_NO 2616 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2634; ORIGINAL_PRECURSOR_SCAN_NO 2632 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2626; ORIGINAL_PRECURSOR_SCAN_NO 2625 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2623; ORIGINAL_PRECURSOR_SCAN_NO 2621 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2643; ORIGINAL_PRECURSOR_SCAN_NO 2642 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2641; ORIGINAL_PRECURSOR_SCAN_NO 2639 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5653; ORIGINAL_PRECURSOR_SCAN_NO 5650 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5671; ORIGINAL_PRECURSOR_SCAN_NO 5668 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5700; ORIGINAL_PRECURSOR_SCAN_NO 5699 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5680; ORIGINAL_PRECURSOR_SCAN_NO 5677 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5706; ORIGINAL_PRECURSOR_SCAN_NO 5702 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5693; ORIGINAL_PRECURSOR_SCAN_NO 5691 Cladribine (2-Chloro-2′-deoxyadenosine), a purine nucleoside analog, is an orally active adenosine deaminase inhibitor. Cladribine functions as an inhibitor of DNA synthesis to block the repair of the damaged DNA. Cladribine can inhibit DNA methylation. Cladribine has anti-lymphoma activity. Cladribine can be used for the research of several hematologic malignancies and multiple sclerosis[1][2].

   

probenecid

Probenecid (Benemid)

C13H19NO4S (285.1035)


M - Musculo-skeletal system > M04 - Antigout preparations > M04A - Antigout preparations > M04AB - Preparations increasing uric acid excretion D018501 - Antirheumatic Agents > D006074 - Gout Suppressants > D014528 - Uricosuric Agents C26170 - Protective Agent > C921 - Uricosuric Agent D010592 - Pharmaceutic Aids

   

2-hydroxy-1,3-dimethoxy-10-methylacridin-9-one

NCGC00384962-01!2-hydroxy-1,3-dimethoxy-10-methylacridin-9-one

C16H15NO4 (285.1001)


   

C16H15NO4_2(1H)-Quinolinone, 3,4-dihydro-3,4-dihydroxy-4-(4-methoxyphenyl)

NCGC00169065-03_C16H15NO4_2(1H)-Quinolinone, 3,4-dihydro-3,4-dihydroxy-4-(4-methoxyphenyl)-

C16H15NO4 (285.1001)


   
   

N4-Acetylcytidine

N4-Acetylcytidine

C11H15N3O6 (285.0961)


CONFIDENCE standard compound; INTERNAL_ID 309

   

7-Aminoclonazepam

7-Aminoclonazepam

C15H12ClN3O (285.0669)


   

2-hydroxy-1,3-dimethoxy-10-methylacridin-9-one [IIN-based: Match]

NCGC00384962-01!2-hydroxy-1,3-dimethoxy-10-methylacridin-9-one [IIN-based: Match]

C16H15NO4 (285.1001)


   

2-hydroxy-1,3-dimethoxy-10-methylacridin-9-one [IIN-based on: CCMSLIB00000848955]

NCGC00384962-01!2-hydroxy-1,3-dimethoxy-10-methylacridin-9-one [IIN-based on: CCMSLIB00000848955]

C16H15NO4 (285.1001)


   
   

2,9;-DEOXYGUANOSINE

2,9;-DEOXYGUANOSINE

C10H15N5O5 (285.1073)


   

8-Chloro-deoxyadenosine

8-Chloro-deoxyadenosine

C10H12Cl1N5O3 (285.0629)


   

2-Chloro-deoxyadenosine

2-Chloro-deoxyadenosine

C10H12Cl1N5O3 (285.0629)


   

4-Acetylcytidine

4-Acetyl-1-(beta-delta-ribofuranosyl)cytosine

C11H15N3O6 (285.0961)


N4-Acetylcytidine is an endogenous metabolite. N4-Acetylcytidine is an endogenous metabolite.

   

3,4-Dihydroxy-4-(4-methoxyphenyl)-3,4-dihydro-2(1H)-quinolinone

3,4-Dihydroxy-4-(4-methoxyphenyl)-3,4-dihydro-2(1H)-quinolinone

C16H15NO4 (285.1001)


   

2-Methyl-2-propanyl N-(3-bromophenyl)glycinate

2-Methyl-2-propanyl N-(3-bromophenyl)glycinate

C12H16BrNO2 (285.0364)


   

2-(BENZOYLAMINO)-4-(METHYLSULFONYL)BUTANOIC ACID

2-(BENZOYLAMINO)-4-(METHYLSULFONYL)BUTANOIC ACID

C12H15NO5S (285.0671)


   

1-(3-bromophenyl)-3,4-dihydroisoquinoline

1-(3-bromophenyl)-3,4-dihydroisoquinoline

C15H12BrN (285.0153)


   

3-[[2-(3-methylphenoxy)acetyl]amino]benzoic acid

3-[[2-(3-methylphenoxy)acetyl]amino]benzoic acid

C16H15NO4 (285.1001)


   

4-HYDROXY-1-[(4-METHYLPHENYL)SULFONYL]-2-PYRROLIDINECARBOXYLIC ACID

4-HYDROXY-1-[(4-METHYLPHENYL)SULFONYL]-2-PYRROLIDINECARBOXYLIC ACID

C12H15NO5S (285.0671)


   

3-AMINO-7-CHLORO-5-PHENYL-1,3-DIHYDRO-BENZO[E][1,4]DIAZEPIN-2-ONE

3-AMINO-7-CHLORO-5-PHENYL-1,3-DIHYDRO-BENZO[E][1,4]DIAZEPIN-2-ONE

C15H12ClN3O (285.0669)


   

Epinastin HCl

Epinastine hydrochloride

C16H16ClN3 (285.1033)


D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Epinastine hydrochloride (WAL801 hydrochloride) is an antihistamine and mast cell stabilizer. Epinastine hydrochloride is a potent, selective and orally-active histamine H1 receptor antagonist. Epinastine hydrochloride also inhibits IL-8 release and has an antiallergic action[1][2][3].

   

1-(Pyridin-3-ylmethyl)piperazine trihydrochloride

1-(Pyridin-3-ylmethyl)piperazine trihydrochloride

C10H18Cl3N3 (285.0566)


   

coumarin 481

2H-1-Benzopyran-2-one, 7-(diethylamino)-4-(trifluoromethyl)-

C14H14F3NO2 (285.0977)


   

4-MORPHOLIN-4-YL-2-PHENYL-BUTYRIC ACID HCL

4-MORPHOLIN-4-YL-2-PHENYL-BUTYRIC ACID HCL

C14H20ClNO3 (285.1132)


   

(2-Methyl-5-(morpholinosulfonyl)phenyl)boronic acid

(2-Methyl-5-(morpholinosulfonyl)phenyl)boronic acid

C11H16BNO5S (285.0842)


   

flunoxaprofen

flunoxaprofen

C16H12FNO3 (285.0801)


M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02C - Other gynecologicals > G02CC - Antiinflammatory products for vaginal administration C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

Anirolac

5-(4-methoxybenzoyl)-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid

C16H15NO4 (285.1001)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

4-Pyridinecarboxylicacid, 2-[(3,4-dimethoxyphenyl)methylene]hydrazide

4-Pyridinecarboxylicacid, 2-[(3,4-dimethoxyphenyl)methylene]hydrazide

C15H15N3O3 (285.1113)


   

2-Fluoroadenosine

2-Fluoroadenosine

C10H12FN5O4 (285.0873)


2-Fluoroadenosine (2FA) is a nucleoside analogue. 2-Fluoroadenosine has antibacterial activity with IC50 value of 0.842 mM for Vibrio microvibrio[1].

   

1-(4-methoxyphenyl)sulfonylpyrrolidine-2-carboxylic acid

1-(4-methoxyphenyl)sulfonylpyrrolidine-2-carboxylic acid

C12H15NO5S (285.0671)


   

Piperazine, 1-[4-(methylsulfonyl)-2-nitrophenyl]- (9CI)

Piperazine, 1-[4-(methylsulfonyl)-2-nitrophenyl]- (9CI)

C11H15N3O4S (285.0783)


   

9-(trifluoromethyl)-5,6,7,8-tetrahydropyrazolo[5,1-b]quinazoline-2-carboxylic acid

9-(trifluoromethyl)-5,6,7,8-tetrahydropyrazolo[5,1-b]quinazoline-2-carboxylic acid

C12H10F3N3O2 (285.0725)


   

Methyl 2-[4-(4-piperidinyloxy)phenyl]acetatehydrochloride

Methyl 2-[4-(4-piperidinyloxy)phenyl]acetatehydrochloride

C14H20ClNO3 (285.1132)


   

2-Deoxy-2-fluoroguanosine

2-Deoxy-2-fluoroguanosine

C10H12FN5O4 (285.0873)


   

(2R,4S)-4-hydroxy-1-(4-methylphenyl)sulfonyl-pyrrolidine-2-carboxylate

(2R,4S)-4-hydroxy-1-(4-methylphenyl)sulfonyl-pyrrolidine-2-carboxylate

C12H15NO5S (285.0671)


   

N-(4-Bromo-2-methylphenyl)-3-methoxy-N-methylpropanamide

N-(4-Bromo-2-methylphenyl)-3-methoxy-N-methylpropanamide

C12H16BrNO2 (285.0364)


   

Methyl 3-(5-Methyl-2-(trifluoromethyl)-1H-indol-3-yl)propanoate

Methyl 3-(5-Methyl-2-(trifluoromethyl)-1H-indol-3-yl)propanoate

C14H14F3NO2 (285.0977)


   

(3S)-3-Benzyl-7a-(trifluoromethyl)tetrahydropyrrolo[2,1-b]oxa-zol-5(6H)-one

(3S)-3-Benzyl-7a-(trifluoromethyl)tetrahydropyrrolo[2,1-b]oxa-zol-5(6H)-one

C14H14F3NO2 (285.0977)


   

(3R)-3-Benzyl-7a-(trifluoromethyl)tetrahydropyrrolo[2,1-b]oxazol-5(6H)-one

(3R)-3-Benzyl-7a-(trifluoromethyl)tetrahydropyrrolo[2,1-b]oxazol-5(6H)-one

C14H14F3NO2 (285.0977)


   

3-(Boc-amino)-3-(3-chlorophenyl)-1-propanol

3-(Boc-amino)-3-(3-chlorophenyl)-1-propanol

C14H20ClNO3 (285.1132)


   

ethyltrimethylplumbane

ethyltrimethylplumbane

C5H17Pb (285.1097)


   

2-(3-(4-hydroxyphenyl)propanamido)benzoic acid

2-(3-(4-hydroxyphenyl)propanamido)benzoic acid

C16H15NO4 (285.1001)


   

5-Deoxy-5-fluoro-2,3-O-isopropylidene-D-cytidine

5-Deoxy-5-fluoro-2,3-O-isopropylidene-D-cytidine

C12H16FN3O4 (285.1125)


   

N-(3-Methylsulphonyl-4-nitrophenyl)piperazine

N-(3-Methylsulphonyl-4-nitrophenyl)piperazine

C11H15N3O4S (285.0783)


   

4-(Methylsulfonyl)-3-morpholinobenzoic Acid

4-(Methylsulfonyl)-3-morpholinobenzoic Acid

C12H15NO5S (285.0671)


   

2,3,4,5-Tetrahydro-3-(trifluoroacetyl)-1,5-methano-1H-3-benzazepine-7,8-diamine

2,3,4,5-Tetrahydro-3-(trifluoroacetyl)-1,5-methano-1H-3-benzazepine-7,8-diamine

C13H14F3N3O (285.1089)


   

N-(2,4-DINITROPHENYL)-DL-THREONINE

N-(2,4-DINITROPHENYL)-DL-THREONINE

C10H11N3O7 (285.0597)


   

1-(4-Bromophenyl)-2-(4-morpholinyl)ethanol

1-(4-Bromophenyl)-2-(4-morpholinyl)ethanol

C12H16BrNO2 (285.0364)


   

2-(5-FLUORO-1,3-DIOXO-1,3-DIHYDROISOINDOL-2-YL)BENZOICACID

2-(5-FLUORO-1,3-DIOXO-1,3-DIHYDROISOINDOL-2-YL)BENZOICACID

C15H8FNO4 (285.0437)


   
   

N-BOC-N-METHYL-5-CHLOROANTHRANILICACID

N-BOC-N-METHYL-5-CHLOROANTHRANILICACID

C13H16ClNO4 (285.0768)


   

ANTHRANILICACID,N-BOC-N-METHYL-4-CHLORO

ANTHRANILICACID,N-BOC-N-METHYL-4-CHLORO

C13H16ClNO4 (285.0768)


   

1-(3-PYRROLIDINOPROYL)HOMOPIPERAZINE

1-(3-PYRROLIDINOPROYL)HOMOPIPERAZINE

C16H15NO2S (285.0823)


   

1-(ISOCYANO(TOSYL)METHYL)-2-METHYLBENZENE

1-(ISOCYANO(TOSYL)METHYL)-2-METHYLBENZENE

C16H15NO2S (285.0823)


   

3-(N-HEXYLSULFAMOYL)BENZOIC ACID

3-(N-HEXYLSULFAMOYL)BENZOIC ACID

C13H19NO4S (285.1035)


   

5-METHOXY-3-(METHYLCARBAMOYL)-[1,1-BIPHENYL]-3-CARBOXYLIC ACID

5-METHOXY-3-(METHYLCARBAMOYL)-[1,1-BIPHENYL]-3-CARBOXYLIC ACID

C16H15NO4 (285.1001)


   

2-[4-(1-carboxyethyl)anilino]benzoic acid

2-[4-(1-carboxyethyl)anilino]benzoic acid

C16H15NO4 (285.1001)


   

7-nitro-4-(pyridin-2-ylmethyl)-2H-benzo[b][1,4]oxazin-3(4H)-one

7-nitro-4-(pyridin-2-ylmethyl)-2H-benzo[b][1,4]oxazin-3(4H)-one

C14H11N3O4 (285.075)


   

3-[[2-(4-methylphenoxy)acetyl]amino]benzoic acid

3-[[2-(4-methylphenoxy)acetyl]amino]benzoic acid

C16H15NO4 (285.1001)


   

5-(furan-2-yl)-3-p-tolyl-4,5-dihydro-1h-pyrazole-1-carbothioamide

5-(furan-2-yl)-3-p-tolyl-4,5-dihydro-1h-pyrazole-1-carbothioamide

C15H15N3OS (285.0936)


   

3-Deoxy-3-fluoroguanosine

3-Deoxy-3-fluoroguanosine

C10H12FN5O4 (285.0873)


   
   

tert-butyl N-[(4-methylphenyl)sulfonylmethyl]carbamate

tert-butyl N-[(4-methylphenyl)sulfonylmethyl]carbamate

C13H19NO4S (285.1035)


   

2-AMINO-6-CHLORO-9-(BETA-D-2-DEOXYRIBOFURANOSYL)PURINE

2-AMINO-6-CHLORO-9-(BETA-D-2-DEOXYRIBOFURANOSYL)PURINE

C10H12ClN5O3 (285.0629)


   

Boc-(R)-3-Amino-4-(2-thienyl)-butyric acid

Boc-(R)-3-Amino-4-(2-thienyl)-butyric acid

C13H19NO4S (285.1035)


   

Ethyl N-[(mesitylsulfonyl)oxy]ethanimidate

Ethyl N-[(mesitylsulfonyl)oxy]ethanimidate

C13H19NO4S (285.1035)


   

Leucine, N-[(4-methylphenyl)sulfonyl]-

Leucine, N-[(4-methylphenyl)sulfonyl]-

C13H19NO4S (285.1035)


   

4-Nitrophenylrhamnoside

4-Nitrophenyl α-L-rhamnopyranoside

C12H15NO7 (285.0848)


   

4-bromo-N,N-diethyl-3-methoxybenzamide

4-bromo-N,N-diethyl-3-methoxybenzamide

C12H16BrNO2 (285.0364)


   

1-(3-Bromo-4-fluorobenzoyl)piperidine

1-(3-Bromo-4-fluorobenzoyl)piperidine

C12H13BrFNO (285.0164)


   

4-bromo-N-butyl-3-methoxybenzamide

4-bromo-N-butyl-3-methoxybenzamide

C12H16BrNO2 (285.0364)


   

4-BROMO-N-(TERT-BUTYL)-3-METHOXYBENZAMIDE

4-BROMO-N-(TERT-BUTYL)-3-METHOXYBENZAMIDE

C12H16BrNO2 (285.0364)


   

7,10-Dihydro-8-nitro-7-oxo-1,10-phenanthroline-3-carboxylic acid

7,10-Dihydro-8-nitro-7-oxo-1,10-phenanthroline-3-carboxylic acid

C13H7N3O5 (285.0386)


   

Ethyl 4-oxo-7-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxylate

Ethyl 4-oxo-7-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxylate

C13H10F3NO3 (285.0613)


   

Methyl 8-methyl-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-2-carboxylate

Methyl 8-methyl-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-2-carboxylate

C13H10F3NO3 (285.0613)


   

6-NITRO-4-(PYRIDINE-2-YLMETHYL)-1,4-BENZOXAZIN-3(4H)-ONE

6-NITRO-4-(PYRIDINE-2-YLMETHYL)-1,4-BENZOXAZIN-3(4H)-ONE

C14H11N3O4 (285.075)


   
   

1-pyridin-3-ylmethyl-pyrrolidin-3-ylamine trihydrochloride

1-pyridin-3-ylmethyl-pyrrolidin-3-ylamine trihydrochloride

C10H18Cl3N3 (285.0566)


   

Benzeneacetic acid,2-chloro-a-[[(1,1-dimethylethoxy)carbonyl]amino]-

Benzeneacetic acid,2-chloro-a-[[(1,1-dimethylethoxy)carbonyl]amino]-

C13H16ClNO4 (285.0768)


   
   

4-BROMO-N-(TERT-BUTYL)-2-METHOXYBENZAMIDE

4-BROMO-N-(TERT-BUTYL)-2-METHOXYBENZAMIDE

C12H16BrNO2 (285.0364)


   

4-[2-(4-Bromophenoxy)ethyl]morpholine

4-[2-(4-Bromophenoxy)ethyl]morpholine

C12H16BrNO2 (285.0364)


   

Adenosine,7,8-dihydro-8-oxo-

Adenosine,7,8-dihydro-8-oxo-

C10H15N5O5 (285.1073)


   

N-(3-BROMOPROPYL) 3-BORONOBENZAMIDE

N-(3-BROMOPROPYL) 3-BORONOBENZAMIDE

C10H13BBrNO3 (285.0172)


   

[5-chloro-2-(cyclopropylmethylamino)phenyl]-phenylmethanone

[5-chloro-2-(cyclopropylmethylamino)phenyl]-phenylmethanone

C17H16ClNO (285.092)


   

5-(2-Fluorophenyl)-3-(3-nitrophenyl)-1,2,4-oxadiazole

5-(2-Fluorophenyl)-3-(3-nitrophenyl)-1,2,4-oxadiazole

C14H8FN3O3 (285.055)


   

1-FURAN-2-YL-2-[2-(2-HYDROXY-ETHYLAMINO)-BENZOIMIDAZOL-1-YL]-ETHANONE

1-FURAN-2-YL-2-[2-(2-HYDROXY-ETHYLAMINO)-BENZOIMIDAZOL-1-YL]-ETHANONE

C15H15N3O3 (285.1113)


   

2-CHLORO-N-[2-(3,4-DIETHOXY-PHENYL)-ETHYL]-ACETAMIDE

2-CHLORO-N-[2-(3,4-DIETHOXY-PHENYL)-ETHYL]-ACETAMIDE

C14H20ClNO3 (285.1132)


   

Isoxazole,3-(4-chlorophenyl)-5-(4-methoxyphenyl)-

Isoxazole,3-(4-chlorophenyl)-5-(4-methoxyphenyl)-

C16H12ClNO2 (285.0557)


   

1-[(4-chlorophenyl)methyl]-5-methylindole-2,3-dione

1-[(4-chlorophenyl)methyl]-5-methylindole-2,3-dione

C16H12ClNO2 (285.0557)


   

4-nitrophenyl-beta-l-fucopyranoside

p-Nitrophenyl 6-deoxy-beta-L-galactopyranoside

C12H15NO7 (285.0848)


   
   

4-AMINO-N-(2,3-DIMETHYLPHENYL)BENZAMIDE

4-AMINO-N-(2,3-DIMETHYLPHENYL)BENZAMIDE

C12H16ClN3O3 (285.088)


   

potassium 2-amino-2-methylpropionate octahydrate

potassium 2-amino-2-methylpropionate octahydrate

C4H24KNO10 (285.1037)


   

tert-Butyl (2-bromobenzyl)carbamate

tert-Butyl (2-bromobenzyl)carbamate

C12H16BrNO2 (285.0364)


   

4-[2-(3-Bromophenoxy)ethyl]morpholine

4-[2-(3-Bromophenoxy)ethyl]morpholine

C12H16BrNO2 (285.0364)


   

[4-(3-bromopropylcarbamoyl)phenyl]boronic acid

[4-(3-bromopropylcarbamoyl)phenyl]boronic acid

C10H13BBrNO3 (285.0172)


   
   

Methyl 7-fluoro-6-(phenylamino)-1H-benzo[d]imidazole-5-carboxylate

Methyl 7-fluoro-6-(phenylamino)-1H-benzo[d]imidazole-5-carboxylate

C15H12FN3O2 (285.0914)


   

POTASSIUM [2-(BENZYLOXYCARBONYLAMINO)ETHYL] TRIFLUOROBORATE

POTASSIUM [2-(BENZYLOXYCARBONYLAMINO)ETHYL] TRIFLUOROBORATE

C10H12BF3KNO2 (285.055)


   

(S)-6-(PROPYLAMINO)-5,6,7,8-TETRAHYDRONAPHTHALEN-1-OL HYDROBROMIDE

(S)-6-(PROPYLAMINO)-5,6,7,8-TETRAHYDRONAPHTHALEN-1-OL HYDROBROMIDE

C13H20BrNO (285.0728)


   

(s)-n-boc-(2-chlorophenyl)glycine

(s)-n-boc-(2-chlorophenyl)glycine

C13H16ClNO4 (285.0768)


   
   

N-Boc-4-(Methylsulfonyl)benzylamine

N-Boc-4-(Methylsulfonyl)benzylamine

C13H19NO4S (285.1035)


   

Adenosine, 8-fluoro-

Adenosine, 8-fluoro-

C10H12FN5O4 (285.0873)


   

benzyl N-(1-hydroxy-2-oxo-2-phenylethyl)carbamate

benzyl N-(1-hydroxy-2-oxo-2-phenylethyl)carbamate

C16H15NO4 (285.1001)


   

(3-Bromo-4-Methyl-phenyl)-carbamic acid tert-butyl ester

(3-Bromo-4-Methyl-phenyl)-carbamic acid tert-butyl ester

C12H16BrNO2 (285.0364)


   

4-[2-(2-Bromophenoxy)ethyl]morpholine

4-[2-(2-Bromophenoxy)ethyl]morpholine

C12H16BrNO2 (285.0364)


   
   

3-(4-Bromophenoxy)-N,N-diethyl-1-propanamine

3-(4-Bromophenoxy)-N,N-diethyl-1-propanamine

C13H20BrNO (285.0728)


   

4-(2-PIPERIDINOETHOXY)BENZOIC ACID HYDROCHLORIDE

4-(2-PIPERIDINOETHOXY)BENZOIC ACID HYDROCHLORIDE

C14H20ClNO3 (285.1132)


   

Ethyl 4-hydroxy-8-(trifluoromethyl)quinoline-3-carboxylate

Ethyl 4-hydroxy-8-(trifluoromethyl)quinoline-3-carboxylate

C13H10F3NO3 (285.0613)


   

Letrozole related compound B

Letrozole related compound B

C17H11N5 (285.1014)


   

Asenapine

(3aS,12bS)-2-Methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole

C17H16ClNO (285.092)


N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AH - Diazepines, oxazepines, thiazepines and oxepines D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants An organic heterotetracyclic compound that is 2,3,3a,12b-tetrahydrodibenzo[2,3:6,7]oxepino[4,5-c]pyrrole bearing methyl and chloro substituents at positions 2 and 5 respectively. C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Asenapine (Org 5222), an atypical antipsychotic, is an antagonist of serotonin receptors (pKi: 8.4-10.5), adrenoceptors (pKi: 8.9-9.5), dopamine receptors (pKi: 8.9-9.4) and histamine receptors (pKi: 8.2-9.0). Asenapine can be used in the research of schizophrenia and bipolar disorder[1][2].

   

Ethyl 5-fluoro-7-(methylsulphonyl)-1H-indole-2-carboxylate

Ethyl 5-fluoro-7-(methylsulphonyl)-1H-indole-2-carboxylate

C12H12FNO4S (285.0471)


   

dnp-l-threonine

dnp-l-threonine

C10H11N3O7 (285.0597)


   

(R)-3-((tert-butoxycarbonyl)amino)-4-(thiophen-3-yl)butanoic acid

(R)-3-((tert-butoxycarbonyl)amino)-4-(thiophen-3-yl)butanoic acid

C13H19NO4S (285.1035)


   

1-propenyl-2,3-diMethyliMidazoliuM hexafluorophosphate

1-propenyl-2,3-diMethyliMidazoliuM hexafluorophosphate

C8H16F6N2P (285.0955)


   

N-[1-(4-bromophenyl)ethyl]-3-methoxypropanamide

N-[1-(4-bromophenyl)ethyl]-3-methoxypropanamide

C12H16BrNO2 (285.0364)


   

Nifuratel

Nifuratel

C10H11N3O5S (285.0419)


G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D000890 - Anti-Infective Agents > D000935 - Antifungal Agents D000890 - Anti-Infective Agents > D023303 - Oxazolidinones C254 - Anti-Infective Agent > C514 - Antifungal Agent

   

4-bromo-2-ethoxy-N-propylbenzamide

4-bromo-2-ethoxy-N-propylbenzamide

C12H16BrNO2 (285.0364)


   

5-bromo-N-butyl-2-hydroxy-3-methylbenzamide

5-bromo-N-butyl-2-hydroxy-3-methylbenzamide

C12H16BrNO2 (285.0364)


   

N-Benzanilide-4,4-dicarboxylic acid

N-Benzanilide-4,4-dicarboxylic acid

C15H11NO5 (285.0637)


   

DIETHYL(3-AMINOPROPYL)PHOSPHONATE OXALATE SALT

DIETHYL(3-AMINOPROPYL)PHOSPHONATE OXALATE SALT

C9H20NO7P (285.0977)


   

1H-Indole,5-bromo-1-(phenylmethyl)-

1H-Indole,5-bromo-1-(phenylmethyl)-

C15H12BrN (285.0153)


   

1-Butylpyridinium trifluoromethanesulfonate

1-Butylpyridinium trifluoromethanesulfonate

C10H14F3NO3S (285.0646)


   

tert-Butyl 4-bromobenzylcarbamate

tert-Butyl 4-bromobenzylcarbamate

C12H16BrNO2 (285.0364)


   

2-Methyl-2-propanyl (3-bromobenzyl)carbamate

2-Methyl-2-propanyl (3-bromobenzyl)carbamate

C12H16BrNO2 (285.0364)


   

(4-(N-(3-Methylbutanoyl)sulfamoyl)phenyl)boronic acid

(4-(N-(3-Methylbutanoyl)sulfamoyl)phenyl)boronic acid

C11H16BNO5S (285.0842)


   

dimethyl 2-[(2-chloroacetyl)amino]benzene-1,4-dicarboxylate

dimethyl 2-[(2-chloroacetyl)amino]benzene-1,4-dicarboxylate

C12H12ClNO5 (285.0404)


   

3-Quinolinecarboxylicacid, 4-hydroxy-7-(trifluoromethyl)-, ethyl ester

3-Quinolinecarboxylicacid, 4-hydroxy-7-(trifluoromethyl)-, ethyl ester

C13H10F3NO3 (285.0613)


   

2-[4-(5-Bromo-2-pyridinyl)-1-piperazinyl]ethanol

2-[4-(5-Bromo-2-pyridinyl)-1-piperazinyl]ethanol

C11H16BrN3O (285.0477)


   

2-(1-PIPERAZINYL)-QUINOLINEHYDROCHLORIDE

2-(1-PIPERAZINYL)-QUINOLINEHYDROCHLORIDE

C13H17Cl2N3 (285.0799)


   

Boc-(S)-3-Amino-4-(3-thienyl)-butyric acid

Boc-(S)-3-Amino-4-(3-thienyl)-butyric acid

C13H19NO4S (285.1035)


   

(S)-2-((TERT-BUTOXYCARBONYL)AMINO)-2-(4-CHLOROPHENYL)ACETIC ACID

(S)-2-((TERT-BUTOXYCARBONYL)AMINO)-2-(4-CHLOROPHENYL)ACETIC ACID

C13H16ClNO4 (285.0768)


   

(2R)-2-(3-chlorophenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]acetic acid

(2R)-2-(3-chlorophenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]acetic acid

C13H16ClNO4 (285.0768)


   

4-BROMO-2-ETHOXY-N-ISOPROPYLBENZAMIDE

4-BROMO-2-ETHOXY-N-ISOPROPYLBENZAMIDE

C12H16BrNO2 (285.0364)


   

(4-BROMO-2-FLUOROPHENYL)(PIPERIDIN-1-YL)METHANONE

(4-BROMO-2-FLUOROPHENYL)(PIPERIDIN-1-YL)METHANONE

C12H13BrFNO (285.0164)


   

METHYL 5-OXO-6-(PYRIDIN-2-YLAMINO)-1,2,3,5-TETRAHYDROINDOLIZINE-8-CARBOXYLATE

METHYL 5-OXO-6-(PYRIDIN-2-YLAMINO)-1,2,3,5-TETRAHYDROINDOLIZINE-8-CARBOXYLATE

C15H15N3O3 (285.1113)


   

tert-Butyl (3-(bromomethyl)phenyl)carbamate

tert-Butyl (3-(bromomethyl)phenyl)carbamate

C12H16BrNO2 (285.0364)


   

2-Chloro-6-(trifluoromethyl)nicotinonitrile

2-Chloro-6-(trifluoromethyl)nicotinonitrile

C15H15N3O3 (285.1113)


   

7,8-dimethyl-4,5-dioxo-6H-pyrano[3,2-c]quinoline-2-carboxylic acid

7,8-dimethyl-4,5-dioxo-6H-pyrano[3,2-c]quinoline-2-carboxylic acid

C15H11NO5 (285.0637)


   

2-CARBOXY-PHTHALANIC ACID

2-CARBOXY-PHTHALANIC ACID

C15H11NO5 (285.0637)


   

TERT-BUTYL 2-(BROMOMETHYL)PHENYLCARBAMATE

TERT-BUTYL 2-(BROMOMETHYL)PHENYLCARBAMATE

C12H16BrNO2 (285.0364)


   

tert-Butyl (4-(bromomethyl)phenyl)carbamate

tert-Butyl (4-(bromomethyl)phenyl)carbamate

C12H16BrNO2 (285.0364)


   

1,3-Dimethoxy-5-[2-(4-nitro-phenyl)-vinyl]-benzene

1,3-Dimethoxy-5-[2-(4-nitro-phenyl)-vinyl]-benzene

C16H15NO4 (285.1001)


   

(+)-PD 128,907 HCl

(+)-PD 128,907 HCl

C14H20ClNO3 (285.1132)


(+)-PD 128907 hydrochloride is a selective dopamine D2/D3 receptor agonist, with Kis of 1.7, 0.84 nM for human and rat D3 receptors, 179, 770 n M for human and rat D3 receptors, respectively.

   

2-nitrophenyl β-D-fucoside

Orthonitrophenyl-beta-D-fucopyranoside

C12H15NO7 (285.0848)


   

1-(ISOCYANO(TOSYL)METHYL)-3-METHYLBENZENE

1-(ISOCYANO(TOSYL)METHYL)-3-METHYLBENZENE

C16H15NO2S (285.0823)


   

Ethyl 4-hydroxy-2-(trifluoromethyl)quinoline-3-carboxylate

Ethyl 4-hydroxy-2-(trifluoromethyl)quinoline-3-carboxylate

C13H10F3NO3 (285.0613)


   

Ethyl 5-(aminomethyl)-1,3,4-oxadiazole-2-carboxylate

Ethyl 5-(aminomethyl)-1,3,4-oxadiazole-2-carboxylate

C8H10F3N3O5 (285.0573)


   

4-nitrophenyl-beta-d-fucopyranoside

4-nitrophenyl-beta-d-fucopyranoside

C12H15NO7 (285.0848)


   

7-benzoyl-2,4-dimethyl-2,4,7,8,9-pentazabicyclo[4.3.0]nona-8,10-diene-3,5-dione

7-benzoyl-2,4-dimethyl-2,4,7,8,9-pentazabicyclo[4.3.0]nona-8,10-diene-3,5-dione

C13H11N5O3 (285.0862)


   

1-(4-METHYL-2-(4-(TRIFLUOROMETHYL)PHENYL)THIAZOL-5-YL)ETHANONE

1-(4-METHYL-2-(4-(TRIFLUOROMETHYL)PHENYL)THIAZOL-5-YL)ETHANONE

C13H10F3NOS (285.0435)


   

ethyl 2-(4-acetamidophenyl)sulfonylacetate

ethyl 2-(4-acetamidophenyl)sulfonylacetate

C12H15NO5S (285.0671)


   

sodium N-benzylsulphanilate

sodium N-benzylsulphanilate

C13H12NNaO3S (285.0436)


   

3-{[(tert-Butoxycarbonyl)amino]methyl}-4-chlorobenzoic acid

3-{[(tert-Butoxycarbonyl)amino]methyl}-4-chlorobenzoic acid

C13H16ClNO4 (285.0768)


   

N-(4-Methylsulphonyl-3-nitrophenyl)piperazine

N-(4-Methylsulphonyl-3-nitrophenyl)piperazine

C11H15N3O4S (285.0783)


   

(S)-ethyl 2-(1-(tert-butoxycarbonyl)ethyl)thiazole-5-carboxylate

(S)-ethyl 2-(1-(tert-butoxycarbonyl)ethyl)thiazole-5-carboxylate

C13H19NO4S (285.1035)


   

n-benzoyl-l-tyrosine

n-benzoyl-l-tyrosine

C16H15NO4 (285.1001)


   

3-Benzyloxy-4-methoxy-beta-nitrostyrene

3-Benzyloxy-4-methoxy-beta-nitrostyrene

C16H15NO4 (285.1001)


   

4-(Methylsulfonyl)-2-morpholinobenzoic Acid

4-(Methylsulfonyl)-2-morpholinobenzoic Acid

C12H15NO5S (285.0671)


   

2-[2-chloro-3-[(2-methylpropan-2-yl)oxycarbonylamino]phenyl]acetic acid

2-[2-chloro-3-[(2-methylpropan-2-yl)oxycarbonylamino]phenyl]acetic acid

C13H16ClNO4 (285.0768)


   

4-benzyloxy-3-methoxy-omega-nitrostyrene

4-benzyloxy-3-methoxy-omega-nitrostyrene

C16H15NO4 (285.1001)


   

CARBAMIC ACID, N-(2-BROMO-4-METHYLPHENYL)-, 1,1-DIMETHYLETHYL ESTER

CARBAMIC ACID, N-(2-BROMO-4-METHYLPHENYL)-, 1,1-DIMETHYLETHYL ESTER

C12H16BrNO2 (285.0364)


   

8-(4-fluorophenyl)-2-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine

8-(4-fluorophenyl)-2-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine

C13H11F4N3 (285.0889)


   

N-Boc-(4-Chlorophenyl)glycine

N-Boc-(4-Chlorophenyl)glycine

C13H16ClNO4 (285.0768)


   

N-Boc-(3-chlorophenyl)glycine

N-Boc-(3-chlorophenyl)glycine

C13H16ClNO4 (285.0768)


   

4-METHYL-3-(MORPHOLINE-4-SULFONYL)BENZOICACID

4-METHYL-3-(MORPHOLINE-4-SULFONYL)BENZOICACID

C12H15NO5S (285.0671)


   

4-(4-(HYDROXYMETHYL)-2-METHOXY-5-NITROPHENOXY)BUTANOIC ACID

4-(4-(HYDROXYMETHYL)-2-METHOXY-5-NITROPHENOXY)BUTANOIC ACID

C12H15NO7 (285.0848)


   

1-METHYL-4-(4-NITRO-BENZENESULFONYL)-PIPERAZINE

1-METHYL-4-(4-NITRO-BENZENESULFONYL)-PIPERAZINE

C11H15N3O4S (285.0783)


   

5-(1-methylcyclopropyl)-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxylic acid

5-(1-methylcyclopropyl)-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxylic acid

C12H10F3N3O2 (285.0725)


   

Trans-3-benzyloxy-4-methoxy-beta-nitrostyrene

Trans-3-benzyloxy-4-methoxy-beta-nitrostyrene

C16H15NO4 (285.1001)


   

2-DEOXYGUANOSINE HYDRATE

2-DEOXYGUANOSINE HYDRATE

C10H15N5O5 (285.1073)


   

METHYL 2-(MORPHOLINOSULFONYL)BENZOATE

METHYL 2-(MORPHOLINOSULFONYL)BENZOATE

C12H15NO5S (285.0671)


   

Acid Mordant Orange 14

Acid Mordant Orange 14

C14H7NO6 (285.0273)


   

2-BOC-AMINO-4-BROMOTOLUENE

2-BOC-AMINO-4-BROMOTOLUENE

C12H16BrNO2 (285.0364)


   

METHYL 3-METHYL-5-[4-(TRIFLUOROMETHYL)PHENYL]ISOXAZOLE-4-CARBOXYLATE

METHYL 3-METHYL-5-[4-(TRIFLUOROMETHYL)PHENYL]ISOXAZOLE-4-CARBOXYLATE

C13H10F3NO3 (285.0613)


   

Pentyl 4-amino-3-bromobenzoate

Pentyl 4-amino-3-bromobenzoate

C12H16BrNO2 (285.0364)


   

1-methylsulfonyl-4-(4-nitrophenyl)piperazine

1-methylsulfonyl-4-(4-nitrophenyl)piperazine

C11H15N3O4S (285.0783)


   

(2-CHLORO-4-MORPHOLINOTHIENO[3,2-D]PYRIMIDIN-6-YL)METHANOL

(2-CHLORO-4-MORPHOLINOTHIENO[3,2-D]PYRIMIDIN-6-YL)METHANOL

C11H12ClN3O2S (285.0339)


   

tert-Butyl N-(4-bromo-2-methylphenyl)carbamate

tert-Butyl N-(4-bromo-2-methylphenyl)carbamate

C12H16BrNO2 (285.0364)


   

TERT-BUTYL 3-IODOPROPYLCARBAMATE

TERT-BUTYL 3-IODOPROPYLCARBAMATE

C8H16INO2 (285.0226)


   

L-GAMMA-GLUTAMYL-P-NITROANILIDE MONOHYDRATE

L-GAMMA-GLUTAMYL-P-NITROANILIDE MONOHYDRATE

C11H15N3O6 (285.0961)


   

2-(4-Dimethylamino-2-hydroxy-benzoyl)-benzoic acid

2-(4-Dimethylamino-2-hydroxy-benzoyl)-benzoic acid

C16H15NO4 (285.1001)


   

5-BROMO-N-(2-MORPHOLINOETHYL)PYRIDIN-2-AMINE

5-BROMO-N-(2-MORPHOLINOETHYL)PYRIDIN-2-AMINE

C11H16BrN3O (285.0477)


   

6-[[(4-Methylphenyl)sulphonyl]amino]hexanoic acid

6-[[(4-Methylphenyl)sulphonyl]amino]hexanoic acid

C13H19NO4S (285.1035)


   

(3-BROMO-5-MORPHOLINOPHENYL)BORONIC ACID

(3-BROMO-5-MORPHOLINOPHENYL)BORONIC ACID

C10H13BBrNO3 (285.0172)


   

ETHYL 5-(4-(TRIFLUOROMETHYL)PHENYL)ISOXAZOLE-3-CARBOXYLATE

ETHYL 5-(4-(TRIFLUOROMETHYL)PHENYL)ISOXAZOLE-3-CARBOXYLATE

C13H10F3NO3 (285.0613)


   

BENZYL (4-BROMOBUTYL)CARBAMATE

BENZYL (4-BROMOBUTYL)CARBAMATE

C12H16BrNO2 (285.0364)


   

m-chlorophenoxysilatrane

m-chlorophenoxysilatrane

C12H16ClNO3Si (285.0588)


   

4-[2-(1-Pipiridine)ethoxybenzoic acid hydrochloride

4-[2-(1-Pipiridine)ethoxybenzoic acid hydrochloride

C14H20ClNO3 (285.1132)


   

Boc-(S)-3-Amino-4-(2-thienyl)-butyric acid

Boc-(S)-3-Amino-4-(2-thienyl)-butyric acid

C13H19NO4S (285.1035)


   

Ethyl 4-hydroxy-6-(trifluoromethyl)quinoline-3-carboxylate

Ethyl 4-hydroxy-6-(trifluoromethyl)quinoline-3-carboxylate

C13H10F3NO3 (285.0613)


   

3-(perfluorophenyl)benzo[c]isoxazole

3-(perfluorophenyl)benzo[c]isoxazole

C13H4F5NO (285.0213)


   

4-[(TETRAHYDRO-FURAN-2-YLMETHYL)-SULFAMOYL]-BENZOIC ACID

4-[(TETRAHYDRO-FURAN-2-YLMETHYL)-SULFAMOYL]-BENZOIC ACID

C12H15NO5S (285.0671)


   

N-(4-Cyclopropyl-1-naphthalenyl)-2-formylhydrazinecarbothioamide

N-(4-Cyclopropyl-1-naphthalenyl)-2-formylhydrazinecarbothioamide

C15H15N3OS (285.0936)


   

[3-(methylthio)-1-(3-phenyl-1,2,4-oxadiazol-5-yl)propyl]amine hydrochloride

[3-(methylthio)-1-(3-phenyl-1,2,4-oxadiazol-5-yl)propyl]amine hydrochloride

C12H16ClN3OS (285.0703)


   

6-Azido-6-deoxy-D-galactopyranose 1-(dihydrogen phosphate)

6-Azido-6-deoxy-D-galactopyranose 1-(dihydrogen phosphate)

C6H12N3O8P (285.0362)


   

(R)-2-(2-Chloro-5-(trifluoromethyl)phenyl)pyrrolidine hydrochloride

(R)-2-(2-Chloro-5-(trifluoromethyl)phenyl)pyrrolidine hydrochloride

C11H12Cl2F3N (285.0299)


   

N-octyl-4-metylpyridinium bromide

N-octyl-4-metylpyridinium bromide

C14H24BrN (285.1092)


   

Methyl N-(2-pyrazinylcarbonyl)phenylalaninate

Methyl N-(2-pyrazinylcarbonyl)phenylalaninate

C15H15N3O3 (285.1113)


   

2-Azido-1,3-dimethylimidazolinium hexafluorophosphate

2-Azido-1,3-dimethylimidazolinium hexafluorophosphate

C5H10F6N5P (285.0578)


   

1-BENZYL-4-BROMO-1H-INDOLE

1-BENZYL-4-BROMO-1H-INDOLE

C15H12BrN (285.0153)


   

3-BROMO-N-(TERT-BUTYL)-4-METHOXYBENZAMIDE

3-BROMO-N-(TERT-BUTYL)-4-METHOXYBENZAMIDE

C12H16BrNO2 (285.0364)


   

5-(3-TRIFLUOROMETHYLPHENYL)-ISOXAZOLE-3-CARBOXYLIC ACID ETHYL ESTER

5-(3-TRIFLUOROMETHYLPHENYL)-ISOXAZOLE-3-CARBOXYLIC ACID ETHYL ESTER

C13H10F3NO3 (285.0613)


   

2-{[(4-Methoxy-3-Methyl-2-Pyridinyl)Methyl]Sulfanyl}-1H-Benzimidazole

2-{[(4-Methoxy-3-Methyl-2-Pyridinyl)Methyl]Sulfanyl}-1H-Benzimidazole

C15H15N3OS (285.0936)


   

1-(PHENYLSULFONYL)-1H-INDOLE-2-CARBALDEHYDE

1-(PHENYLSULFONYL)-1H-INDOLE-2-CARBALDEHYDE

C15H11NO3S (285.046)


   

(4-Methoxy-3-(pyrrolidin-1-ylsulfonyl)phenyl)boronic acid

(4-Methoxy-3-(pyrrolidin-1-ylsulfonyl)phenyl)boronic acid

C11H16BNO5S (285.0842)


   

(1-Tosylpyrrolidine-2,5-diyl)dimethanol

(1-Tosylpyrrolidine-2,5-diyl)dimethanol

C13H19NO4S (285.1035)


   

1-(5-Bromo-2-fluorobenzyl)-4-methylpiperidine

1-(5-Bromo-2-fluorobenzyl)-4-methylpiperidine

C13H17BrFN (285.0528)


   

1-BOC-5,6-DICHLORO-1H-INDOLE

1-BOC-5,6-DICHLORO-1H-INDOLE

C13H13Cl2NO2 (285.0323)


   

(2-Methyl-4-(morpholinosulfonyl)phenyl)boronic acid

(2-Methyl-4-(morpholinosulfonyl)phenyl)boronic acid

C11H16BNO5S (285.0842)


   

N-Boc-2-(4-chlorophenyl)-DL-glycine

N-Boc-2-(4-chlorophenyl)-DL-glycine

C13H16ClNO4 (285.0768)


   

N-(2,3,5,6-Tetramethylphenylsulfonyl)-^b-alanine

N-(2,3,5,6-Tetramethylphenylsulfonyl)-^b-alanine

C13H19NO4S (285.1035)


   

2,5-Pyrrolidinedicarboxylic acid, 1-(phenylmethyl)-, hydrochloride (9CI)

2,5-Pyrrolidinedicarboxylic acid, 1-(phenylmethyl)-, hydrochloride (9CI)

C13H16ClNO4 (285.0768)


   

1-(2-nitrophenyl)sulfonylpiperidin-4-amine

1-(2-nitrophenyl)sulfonylpiperidin-4-amine

C11H15N3O4S (285.0783)


   

1-[2-(4-CHLOROPHENYL)-7-METHYLPYRAZOLO[1,5-A]PYRIMIDIN-6-YL]ETHAN-1-ONE

1-[2-(4-CHLOROPHENYL)-7-METHYLPYRAZOLO[1,5-A]PYRIMIDIN-6-YL]ETHAN-1-ONE

C15H12ClN3O (285.0669)


   

N-octyl-3-metylpyridinium bromide

N-octyl-3-metylpyridinium bromide

C14H24BrN (285.1092)


   

2′-Deoxy-2′-fluoroguanosine

2′-Deoxy-2′-fluoroguanosine

C10H12FN5O4 (285.0873)


2′-Deoxy-2′-fluoroguanosine, a nucleoside analog, is a potent inhibitor of influenza virus strains, with an EC90 of <0.35 μM for influenza virus A and B strains. 2′-Deoxy-2′-fluoroguanosine significantly inhibits replication of influenza virus in the upper respiratory tract, resulting in amelioration of fever and nasal inflammation[1][2].

   

2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-benzothiophene-5-carbonitrile

2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-benzothiophene-5-carbonitrile

C15H16BNO2S (285.0995)


   

2-AMINOPHENYL-β-D-GLUCURONIC ACID

2-AMINOPHENYL-β-D-GLUCURONIC ACID

C12H15NO7 (285.0848)


   

Adenosine,8-chloro-2-deoxy- (9CI)

Adenosine,8-chloro-2-deoxy- (9CI)

C10H12ClN5O3 (285.0629)


   

1-Isocyano-2-phenylethyl 4-methylphenyl sulfone

1-Isocyano-2-phenylethyl 4-methylphenyl sulfone

C16H15NO2S (285.0823)


   

10-Methoxyiminostilbene-5-carbonylchloride

10-Methoxyiminostilbene-5-carbonylchloride

C16H12ClNO2 (285.0557)


   

1-(Phenylsulfonyl)-3-indolecarboxaldehyde

1-(Phenylsulfonyl)-3-indolecarboxaldehyde

C15H11NO3S (285.046)


   
   

2-Bromo-N-cyclopentyl-5-fluorobenzamide

2-Bromo-N-cyclopentyl-5-fluorobenzamide

C12H13BrFNO (285.0164)


   

N-(5-METHYLSULPHONYL-2-NITROPHENYL)PIPERAZINE

N-(5-METHYLSULPHONYL-2-NITROPHENYL)PIPERAZINE

C11H15N3O4S (285.0783)


   

3-(Boc-amino)-3-(4-chlorophenyl)-1-propanol

3-(Boc-amino)-3-(4-chlorophenyl)-1-propanol

C14H20ClNO3 (285.1132)


   

Dibenzyl imidodicarbonate

Dibenzyl imidodicarbonate

C16H15NO4 (285.1001)


   

methyl 5-bromo-2-(2-methylpropylamino)benzoate

methyl 5-bromo-2-(2-methylpropylamino)benzoate

C12H16BrNO2 (285.0364)


   

Methyl 3-bromo-4-(diethylamino)benzoate

Methyl 3-bromo-4-(diethylamino)benzoate

C12H16BrNO2 (285.0364)


   

3-bromo-4-(diethylaminomethyl)benzoic acid

3-bromo-4-(diethylaminomethyl)benzoic acid

C12H16BrNO2 (285.0364)


   

N-(2-Aminoethyl)-5-chloroisoquinoline-8-sulfonamide

N-(2-Aminoethyl)-5-chloroisoquinoline-8-sulfonamide

C11H12ClN3O2S (285.0339)


CKI-7 free base is a potent and ATP-competitive casein kinase 1 (CK1) inhibitor with an IC50 of 6 μM and a Ki of 8.5 μM. CKI-7 free base is a selective Cdc7 kinase inhibitor. CKI-7 free base also inhibits SGK, ribosomal S6 kinase-1 (S6K1) and mitogen- and stress-activated protein kinase-1 (MSK1). CKI-7 free base has a much weaker effect on casein kinase II and other protein kinases[1][2][3][4].

   

N-(beta-D-glucosyl)nicotinate

N-(beta-D-glucosyl)nicotinate

C12H15NO7 (285.0848)


   

9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine

9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine

C13H8ClN5O (285.0417)


CGS 15943 is an orally bioavailable non-xanthine Adenosine Receptor antagonist. Its Ki for human A1, A2A, A2B, and A3 Adenosine Receptors are 3.5, 4.2, 16, and 50 nM in transfected CHO cells, respectively. [1][2].

   

2-(6-Amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

2-(6-Amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C10H12FN5O4 (285.0873)


D000970 - Antineoplastic Agents

   

5-BENZOXAZOLEACETIC ACID, 2-(4-FLUOROPHENYL)-alpha-METHYL-

5-BENZOXAZOLEACETIC ACID, 2-(4-FLUOROPHENYL)-alpha-METHYL-

C16H12FNO3 (285.0801)


   

5-(6-Amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol

5-(6-Amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol

C10H12ClN5O3 (285.0629)


   

2-Benzamido-3-(4-hydroxyphenyl)propanoic acid

2-Benzamido-3-(4-hydroxyphenyl)propanoic acid

C16H15NO4 (285.1001)


   

N-(2-furanylmethyl)-3-methyl-7,8-dihydro-6H-cyclopenta[4,5]thieno[1,2-c]pyrimidin-1-amine

N-(2-furanylmethyl)-3-methyl-7,8-dihydro-6H-cyclopenta[4,5]thieno[1,2-c]pyrimidin-1-amine

C15H15N3OS (285.0936)


   

5-(N-Methyl-N-propyl)amiloride

5-(N-Methyl-N-propyl)amiloride

C10H16ClN7O (285.1105)


   

2-[(1-Oxo-2-phenoxyethyl)amino]benzoic acid methyl ester

2-[(1-Oxo-2-phenoxyethyl)amino]benzoic acid methyl ester

C16H15NO4 (285.1001)


   

5-methyl-N-[4-(2-pyridinyl)-2-thiazolyl]-2-furancarboxamide

5-methyl-N-[4-(2-pyridinyl)-2-thiazolyl]-2-furancarboxamide

C14H11N3O2S (285.0572)


   

2,3-Secoguanosine

2,3-Secoguanosine

C10H15N5O5 (285.1073)


   

3-[2-(3-Methylphenoxy)ethyl]-1,3-benzothiazol-2-one

3-[2-(3-Methylphenoxy)ethyl]-1,3-benzothiazol-2-one

C16H15NO2S (285.0823)


   

3-[2-(4-Methylphenoxy)ethyl]-1,3-benzothiazol-2-one

3-[2-(4-Methylphenoxy)ethyl]-1,3-benzothiazol-2-one

C16H15NO2S (285.0823)


   

4-N-hydroxy-1-N-(2-pyridin-4-ylethyl)benzene-1,4-dicarboxamide

4-N-hydroxy-1-N-(2-pyridin-4-ylethyl)benzene-1,4-dicarboxamide

C15H15N3O3 (285.1113)


   

Acetamide, N-(2,3-dihydroxy-5-(4-methylbenzoyl)phenyl)-

Acetamide, N-(2,3-dihydroxy-5-(4-methylbenzoyl)phenyl)-

C16H15NO4 (285.1001)


   

2-(3-Benzoylphenoxy)ethyl(hydroxy)formamide

2-(3-Benzoylphenoxy)ethyl(hydroxy)formamide

C16H15NO4 (285.1001)


   

3-Nitro-4-(2-oxo-pyrrolidin-1-yl)-benzenesulfonamide

3-Nitro-4-(2-oxo-pyrrolidin-1-yl)-benzenesulfonamide

C10H11N3O5S (285.0419)


   

1,8-DI-Hydroxy-4-nitro-anthraquinone

1,8-DI-Hydroxy-4-nitro-anthraquinone

C14H7NO6 (285.0273)


   

2-[4-(Dimethylamino)phenyl]-6-Hydroxy-3-Methyl-1,3-Benzothiazol-3-Ium

2-[4-(Dimethylamino)phenyl]-6-Hydroxy-3-Methyl-1,3-Benzothiazol-3-Ium

C16H17N2OS+ (285.1062)


   

Femara

4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile

C17H11N5 (285.1014)


L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BG - Aromatase inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D047072 - Aromatase Inhibitors C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist D000970 - Antineoplastic Agents Letrozole (CGS 20267) is a potent, selective, reversible and orally active non-steroidal inhibitor of aromatase, with an IC50 of 11.5 nM. Letrozole selective inhibits estrogen biosynthesis, and can be used for the research of breast cancer[1][2][3].

   

3,4-Dihydroxy-4-(4-methoxyphenyl)-1,3-dihydroquinolin-2-one

3,4-Dihydroxy-4-(4-methoxyphenyl)-1,3-dihydroquinolin-2-one

C16H15NO4 (285.1001)


   

N-[1-[(2R,3S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide

N-[1-[(2R,3S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide

C11H15N3O6 (285.0961)


   

Kaempferol oxoanion

Kaempferol oxoanion

C15H9O6- (285.0399)


The 3-oxoanion of kaempferol.

   

Cyanidin(1-)

Cyanidin(1-)

C15H9O6- (285.0399)


An organic anion obtained by selective deprotonation of the 3- and 5-hydroxy groups of cyanidin(1+).

   
   

5,7,2,4-Tetrahydroxyisoflavone

5,7,2,4-Tetrahydroxyisoflavone

C15H9O6- (285.0399)


   

(1S,2R)-1-(1H-indol-3-yl)-3-(phosphonatooxy)propane-1,2-diol

(1S,2R)-1-(1H-indol-3-yl)-3-(phosphonatooxy)propane-1,2-diol

C11H12NO6P-2 (285.0402)


   

5-Phosphoribosylglycineamide

5-Phosphoribosylglycineamide

C7H14N2O8P- (285.0488)


   

2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-olate luteolin-7-olate(1-)

2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-olate luteolin-7-olate(1-)

C15H9O6- (285.0399)


   
   

2-Amino-4,5-dihydroxy-6-oxo-7-(phosphooxy)heptanoate

2-Amino-4,5-dihydroxy-6-oxo-7-(phosphooxy)heptanoate

C7H12NO9P-2 (285.025)


   

Fisetin(1-)

Fisetin(1-)

C15H9O6- (285.0399)


A flavonoid oxoanion that is the conjugate base of fisetin.

   

gentisate 5-O-beta-D-xylopyranoside

gentisate 5-O-beta-D-xylopyranoside

C12H13O8- (285.061)


D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates

   

(Z)-3-(4-hydroxy-2-methoxyphenyl)-1-(4-hydroxyphenyl)-3-oxoprop-1-en-1-olate

(Z)-3-(4-hydroxy-2-methoxyphenyl)-1-(4-hydroxyphenyl)-3-oxoprop-1-en-1-olate

C16H13O5- (285.0763)


   

5-amino-4-chloro-2-(2-hydroxymuconoyl)pyridazin-3(2H)-one

5-amino-4-chloro-2-(2-hydroxymuconoyl)pyridazin-3(2H)-one

C10H8ClN3O5 (285.0152)


   

4-dihydro-9-hydroxy-1-methyl-10-oxo-3-H-naptho-[2,3-c]-pyran-3-(S)-acetic acid

4-dihydro-9-hydroxy-1-methyl-10-oxo-3-H-naptho-[2,3-c]-pyran-3-(S)-acetic acid

C16H13O5- (285.0763)


   

1,6,7,8-tetrahydroxy-2-methylanthraquinone

1,6,7,8-tetrahydroxy-2-methylanthraquinone

C15H9O6- (285.0399)


   

3-(2,4-Dihydroxyphenyl)-4,7-dihydroxycoumarin

3-(2,4-Dihydroxyphenyl)-4,7-dihydroxycoumarin

C15H9O6- (285.0399)


   

3,5,6,7-Tetrahydroxy-2-(4-hydroxyphenyl)chromenium

3,5,6,7-Tetrahydroxy-2-(4-hydroxyphenyl)chromenium

C15H9O6- (285.0399)


   

(2S,4R,5R,6R)-6-(4-amino-2-oxopyrimidin-1-yl)-4,5-dihydroxy-3-oxooxane-2-carboxylic acid

(2S,4R,5R,6R)-6-(4-amino-2-oxopyrimidin-1-yl)-4,5-dihydroxy-3-oxooxane-2-carboxylic acid

C10H11N3O7 (285.0597)


   

2-(6-amino-2-fluoro-7H-purin-8-yl)oxane-3,4,5-triol

2-(6-amino-2-fluoro-7H-purin-8-yl)oxane-3,4,5-triol

C10H12FN5O4 (285.0873)


   

1-C-(indol-3-yl)glycerol 3-phosphate(2-)

1-C-(indol-3-yl)glycerol 3-phosphate(2-)

C11H12NO6P-2 (285.0402)


   

N(1)-(5-phospho-D-ribosyl)glycinamide(1-)

N(1)-(5-phospho-D-ribosyl)glycinamide(1-)

C7H14N2O8P- (285.0488)


Conjugate base of N(1)-(5-phospho-D-ribosyl)glycinamide. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Scutellarein(1-)

Scutellarein(1-)

C15H9O6- (285.0399)


A flavonoid oxoanion that is the conjugate base of scutellarein, obtained by selective deprotonation of the 7-hydroxy group. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

   

4-butyl-3-(4-chloro-1,5-dimethyl-3-pyrazolyl)-1H-1,2,4-triazole-5-thione

4-butyl-3-(4-chloro-1,5-dimethyl-3-pyrazolyl)-1H-1,2,4-triazole-5-thione

C11H16ClN5S (285.0815)


   

N-(1-propyl-5-benzimidazolyl)-2-thiophenecarboxamide

N-(1-propyl-5-benzimidazolyl)-2-thiophenecarboxamide

C15H15N3OS (285.0936)


   

3-[4-(2-methylphenyl)-5-sulfanylidene-1H-1,2,4-triazol-3-yl]-1H-pyridazin-6-one

3-[4-(2-methylphenyl)-5-sulfanylidene-1H-1,2,4-triazol-3-yl]-1H-pyridazin-6-one

C13H11N5OS (285.0684)


   

N-(3-bicyclo[2.2.1]heptanyl)-4-chlorobenzenesulfonamide

N-(3-bicyclo[2.2.1]heptanyl)-4-chlorobenzenesulfonamide

C13H16ClNO2S (285.059)


   

7-Chloro-2-methyl-3-(pyridin-4-ylmethyl)quinazolin-4-one

7-Chloro-2-methyl-3-(pyridin-4-ylmethyl)quinazolin-4-one

C15H12ClN3O (285.0669)


   

2-O-methyllicodione(1-)

2-O-methyllicodione(1-)

C16H13O5- (285.0763)


   

N-(5-amino-1-phenyl-1,2,4-triazol-3-yl)-2-thiophenecarboxamide

N-(5-amino-1-phenyl-1,2,4-triazol-3-yl)-2-thiophenecarboxamide

C13H11N5OS (285.0684)


   

1-Butyl-3-[[(4,5-dimethyl-3-thiophenyl)-oxomethyl]amino]thiourea

1-Butyl-3-[[(4,5-dimethyl-3-thiophenyl)-oxomethyl]amino]thiourea

C12H19N3OS2 (285.0969)


   

N-[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]-2-thiophenecarboxamide

N-[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]-2-thiophenecarboxamide

C14H11N3O2S (285.0572)


   

1-Tert-butyl-3-[[(2-chlorophenyl)-oxomethyl]amino]thiourea

1-Tert-butyl-3-[[(2-chlorophenyl)-oxomethyl]amino]thiourea

C12H16ClN3OS (285.0703)


   

3-(3-Pyridinylmethylthio)-6-thiophen-2-ylpyridazine

3-(3-Pyridinylmethylthio)-6-thiophen-2-ylpyridazine

C14H11N3S2 (285.0394)


   

N-[3-(6-imidazo[2,1-b]thiazolyl)phenyl]butanamide

N-[3-(6-imidazo[2,1-b]thiazolyl)phenyl]butanamide

C15H15N3OS (285.0936)


   

2-(4-Chloro-2-methylphenoxy)acetic acid [2-(ethylamino)-2-oxoethyl] ester

2-(4-Chloro-2-methylphenoxy)acetic acid [2-(ethylamino)-2-oxoethyl] ester

C13H16ClNO4 (285.0768)


   

(3-Chloro-phenyl)-(6,7-dihydro-5H-cyclopenta[d][1,2,4]triazolo[1,5-a]pyrimidin-8-yl)-amine

(3-Chloro-phenyl)-(6,7-dihydro-5H-cyclopenta[d][1,2,4]triazolo[1,5-a]pyrimidin-8-yl)-amine

C14H12ClN5 (285.0781)


   

rubrofusarin B(1-)

rubrofusarin B(1-)

C16H13O5- (285.0763)


A phenolate anion obtained by deprotonation of the 5-hydroxy group of rubrofusarin B. It is the major microspecies at pH 7.3.

   

6-chloro-4-hydroxy-3-(phenylmethyl)-1H-quinolin-2-one

6-chloro-4-hydroxy-3-(phenylmethyl)-1H-quinolin-2-one

C16H12ClNO2 (285.0557)


   

(2R,5R)-2-(6-amino-2-fluoro-9-purinyl)-5-(hydroxymethyl)oxolane-3,4-diol

(2R,5R)-2-(6-amino-2-fluoro-9-purinyl)-5-(hydroxymethyl)oxolane-3,4-diol

C10H12FN5O4 (285.0873)


   

(3R)-5-(6-amino-2-chloro-9-purinyl)-2-(hydroxymethyl)-3-oxolanol

(3R)-5-(6-amino-2-chloro-9-purinyl)-2-(hydroxymethyl)-3-oxolanol

C10H12ClN5O3 (285.0629)


   

Aureusidin-6-olate

Aureusidin-6-olate

C15H9O6- (285.0399)


An organic anion that is the conjugate base of aureusidin, arising from selective deprotonation of the hydroxy group at position 6 of the benzofuran moiety; major species at pH 7.3.

   

6beta-[(S)-1-hydroxyethyl]-2-[(R)-tetrahydrofuran-2-yl]pen-2-em-3-carboxylic acid

6beta-[(S)-1-hydroxyethyl]-2-[(R)-tetrahydrofuran-2-yl]pen-2-em-3-carboxylic acid

C12H15NO5S (285.0671)


   

5-[2-(2,6-Difluorophenyl)ethyl]-8-quinolinol

5-[2-(2,6-Difluorophenyl)ethyl]-8-quinolinol

C17H13F2NO (285.0965)


   

4-[[4-[Nitroso(oxo)methyl]phenyl]hydrazo]benzoic acid

4-[[4-[Nitroso(oxo)methyl]phenyl]hydrazo]benzoic acid

C14H11N3O4 (285.075)


   
   

N-(D-glucopyranosyl)nicotinate

N-(D-glucopyranosyl)nicotinate

C12H15NO7 (285.0848)


   

2,3-dihydrobiochanin A(1-)

2,3-dihydrobiochanin A(1-)

C16H13O5- (285.0763)


Conjugate base of 2,3-dihydrobiochanin A arising from selective deprotonation of the 7-hydroxy group.

   

(5R)-6-(1-hydroxyethyl)-7-oxo-3-[(2R)-tetrahydrofuran-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

(5R)-6-(1-hydroxyethyl)-7-oxo-3-[(2R)-tetrahydrofuran-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

C12H15NO5S (285.0671)


   

2-hydroxyphenyl beta-D-glucopyranosiduronate

2-hydroxyphenyl beta-D-glucopyranosiduronate

C12H13O8- (285.061)


   

(5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-(oxolan-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

(5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-(oxolan-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

C12H15NO5S (285.0671)


   

3-Methyl-4-thiophen-2-yl-2,4,4a,6,7,8-hexahydropyrazolo[3,4-b]quinolin-5-one

3-Methyl-4-thiophen-2-yl-2,4,4a,6,7,8-hexahydropyrazolo[3,4-b]quinolin-5-one

C15H15N3OS (285.0936)


   

3,4,8-Trihydroxyflavone-7-olate

3,4,8-Trihydroxyflavone-7-olate

C15H9O6- (285.0399)


   

2-methylpropanoic acid [3-(1H-benzimidazol-2-yl)-3-cyano-2-oxopropyl] ester

2-methylpropanoic acid [3-(1H-benzimidazol-2-yl)-3-cyano-2-oxopropyl] ester

C15H15N3O3 (285.1113)


   

(2E)-2-(5-fluoro-2-oxo-1H-indol-3-ylidene)-2-(4-methyl-1,3-thiazol-2-yl)acetonitrile

(2E)-2-(5-fluoro-2-oxo-1H-indol-3-ylidene)-2-(4-methyl-1,3-thiazol-2-yl)acetonitrile

C14H8FN3OS (285.0372)


   

(5R,6S)-6-[(1S)-1-hydroxyethyl]-7-oxo-3-[(2R)-oxolan-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

(5R,6S)-6-[(1S)-1-hydroxyethyl]-7-oxo-3-[(2R)-oxolan-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

C12H15NO5S (285.0671)


   

(1R,10S,11R,12R,13S,14R)-3-amino-11-(hydroxymethyl)-6,9-dioxa-2,4-diazapentacyclo[8.3.1.01,7.05,13.08,12]tetradec-3-ene-8,11,14-triol

(1R,10S,11R,12R,13S,14R)-3-amino-11-(hydroxymethyl)-6,9-dioxa-2,4-diazapentacyclo[8.3.1.01,7.05,13.08,12]tetradec-3-ene-8,11,14-triol

C11H15N3O6 (285.0961)


   

1,3-Dimethoxy-2-hydroxy-10-methyl-9(10h)-acridinone

1,3-Dimethoxy-2-hydroxy-10-methyl-9(10h)-acridinone

C16H15NO4 (285.1001)


   

[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] butanoate

[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] butanoate

C9H20NO7P (285.0977)


   

3,5-Dimethyl-4-nitrobenzyl benzoate

3,5-Dimethyl-4-nitrobenzyl benzoate

C16H15NO4 (285.1001)


   

1-Acetoxy-4-(4-(N-acetylamino)phenoxy)benzene

1-Acetoxy-4-(4-(N-acetylamino)phenoxy)benzene

C16H15NO4 (285.1001)


   

5-Chloro-5-deoxyadenosine

5-Chloro-5-deoxyadenosine

C10H12ClN5O3 (285.0629)


   

Vidarabine monohydrate

Vidarabine monohydrate

C10H13N5O4.H2O (285.1073)


D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent D009676 - Noxae > D000963 - Antimetabolites Vidarabine monohydrate is an adenine arabinoside. Vidarabine monohydrate an antiviral agent which is active against herpes simplex viruses (HSV) and varicella zoster viruses[1].

   

6alpha-[(R)-1-hydroxyethyl]-2-[(R)-tetrahydrofuran-2-yl]pen-2-em-3-carboxylic acid

6alpha-[(R)-1-hydroxyethyl]-2-[(R)-tetrahydrofuran-2-yl]pen-2-em-3-carboxylic acid

C12H15NO5S (285.0671)


   

(S,S)-asenapine

(S,S)-asenapine

C17H16ClNO (285.092)


A 5-chloro-2-methyl-2,3,3a,12b-tetrahydrodibenzo[2,3:6,7]oxepino[4,5-c]pyrrole in which both of the stereocentres have S configuration.

   

(1S,2R)-1-C-(indol-3-yl)glycerol 3-phosphate(2-)

(1S,2R)-1-C-(indol-3-yl)glycerol 3-phosphate(2-)

C11H12NO6P (285.0402)


Dianion of (1S,2R)-1-C-(indol-3-yl)glycerol 3-phosphate arising from deprotonation of both phosphate OH groups.

   
   

2-hydroxygenistein(1-)

2-hydroxygenistein(1-)

C15H9O6 (285.0399)


A flavonoid oxoanion obtained by deprotonation of the 7-hydroxy group of 2-hydroxygenistein. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

   

(R,R)-asenapine

(R,R)-asenapine

C17H16ClNO (285.092)


A 5-chloro-2-methyl-2,3,3a,12b-tetrahydrodibenzo[2,3:6,7]oxepino[4,5-c]pyrrole in which both of the stereocentres have R configuration.

   

1-C-(indol-3-yl)glycerol 3-phosphate(2-)

1-C-(indol-3-yl)glycerol 3-phosphate(2-)

C11H12NO6P (285.0402)


An organophosphate oxoanion resulting the from removal of two protons from the phosphate group of 1-C-(indol-3-yl)glycerol 3-phosphate.

   

luteolin-7-olate

luteolin-7-olate

C15H9O6 (285.0399)


A flavonoid oxoanion that is the conjugate base of luteolin, arising from selective deprotonation of the 7-hydroxy group.

   

4-nitrophenyl alpha-L-fucoside

4-nitrophenyl alpha-L-fucoside

C12H15NO7 (285.0848)


An alpha-L-fucoside that is alpha-L-fucopyranose in which the anomeric hydroxy hydrogen is replaced by a 4-nitrophenyl group.

   

catechol beta-D-glucuronide(1-)

catechol beta-D-glucuronide(1-)

C12H13O8 (285.061)


A carbohydrate acid derivative anion resulting from the removal of a proton from the carboxy group of catechol beta-D-glucuronide.

   

AminoChlorohydroxymuconoyl3(2Hpyridazinone

AminoChlorohydroxymuconoyl3(2Hpyridazinone

C10H8ClN3O5 (285.0152)


   
   

2'-Deoxyguanosine monohydrate

2'-Deoxyguanosine monohydrate

C10H15N5O5 (285.1073)


2'-Deoxyguanosine monohydrate is an endogenous metabolite. 2'-Deoxyguanosine monohydrate is an endogenous metabolite.

   

4'-C-Azidouridine

4'-C-Azidouridine

C9H11N5O6 (285.0709)


4'-C-azidouridine (4'-Azidouridine) is a uridine analogue. Uridine has potential antiepileptic effects, and its analogs can be used to study anticonvulsant and anxiolytic activities, as well as to develop new antihypertensive agents[1]. 4'-C-Azidouridine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.

   

Nucleoside-Analog-2

Nucleoside-Analog-2

C9H11N5O6 (285.0709)


Nucleoside-Analog-2 is a 4'-Azidocytidine analogue against Hepatitis C virus (HCV) replication. Nucleoside-Analog-2 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.

   

PI3K/Akt/mTOR-IN-2

PI3K/Akt/mTOR-IN-2

C17H13F2NO (285.0965)


PI3K/Akt/mTOR-IN-2 is a PI3K/AKT/mTOR pathway inhibitor. PI3K/Akt/mTOR-IN-2 possess anti-cancer effects and selectivity against MDA-MB-231 cells with IC50 value of 2.29 μM. PI3K/Akt/mTOR-IN-2 can induce cancer cell cycle arrest and apoptosis[1].

   

SIRT7 inhibitor 97491

SIRT7 inhibitor 97491

C15H12ClN3O (285.0669)


SIRT7 inhibitor 97491, a potent SIRT7 inhibitor with an IC50 of 325 nM, reduces deacetylase activity of SIRT7 in a dose-dependent manner. SIRT7 inhibitor 97491 prevents tumor progression by increasing p53 stability through acetylation at K373/382. SIRT7 inhibitor 97491 promotes apoptosis through caspase pathway.[1].

   

7-imino-2-methyl-10,13,15-trioxa-6,8-diazapentacyclo[7.4.1.1³,¹².0⁵,¹¹.0⁵,¹⁴]pentadecane-2,4,12-triol

7-imino-2-methyl-10,13,15-trioxa-6,8-diazapentacyclo[7.4.1.1³,¹².0⁵,¹¹.0⁵,¹⁴]pentadecane-2,4,12-triol

C11H15N3O6 (285.0961)


   

4-hydroxy-2,3-dimethoxy-10-methylacridin-9-one

4-hydroxy-2,3-dimethoxy-10-methylacridin-9-one

C16H15NO4 (285.1001)


   

(2r)-2,3-bis(formyloxy)propoxy(2-(methylamino)ethoxy)phosphinic acid

(2r)-2,3-bis(formyloxy)propoxy(2-(methylamino)ethoxy)phosphinic acid

C8H16NO8P (285.0614)


   

2-hydroxy-3-(4-methoxyphenyl)-1,2-dihydroindole-3-carboxylic acid

2-hydroxy-3-(4-methoxyphenyl)-1,2-dihydroindole-3-carboxylic acid

C16H15NO4 (285.1001)


   

2-{[(5-hydroxy-2,5-dimethyl-4,6-dioxocyclohex-2-en-1-ylidene)amino]methyl}benzaldehyde

2-{[(5-hydroxy-2,5-dimethyl-4,6-dioxocyclohex-2-en-1-ylidene)amino]methyl}benzaldehyde

C16H15NO4 (285.1001)


   

methyl 2,7-dimethoxy-9h-carbazole-3-carboxylate

methyl 2,7-dimethoxy-9h-carbazole-3-carboxylate

C16H15NO4 (285.1001)


   

(13r)-16-methyl-13-(prop-1-en-2-yl)-3,5,14-trioxa-16-azatetracyclo[7.7.0.0²,⁶.0¹¹,¹⁵]hexadeca-1,6,8,11(15)-tetraen-10-one

(13r)-16-methyl-13-(prop-1-en-2-yl)-3,5,14-trioxa-16-azatetracyclo[7.7.0.0²,⁶.0¹¹,¹⁵]hexadeca-1,6,8,11(15)-tetraen-10-one

C16H15NO4 (285.1001)


   

(2r,3r)-2-hydroxy-3-(4-methoxyphenyl)-1,2-dihydroindole-3-carboxylic acid

(2r,3r)-2-hydroxy-3-(4-methoxyphenyl)-1,2-dihydroindole-3-carboxylic acid

C16H15NO4 (285.1001)


   

3-methoxy-4-phenyl-3h-quinoline-2,4,6-triol

3-methoxy-4-phenyl-3h-quinoline-2,4,6-triol

C16H15NO4 (285.1001)


   

4a,n-dedihydronoraugustamine

NA

C16H15NO4 (285.1001)


{"Ingredient_id": "HBIN010220","Ingredient_name": "4a,n-dedihydronoraugustamine","Alias": "NA","Ingredient_formula": "C16H15NO4","Ingredient_Smile": "C1CC2=NCCC23C4C1OC(O4)C5=CC6=C(C=C35)OCO6","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4865","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

2-[(4s,7r)-10-chloro-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-4-yl]acetonitrile

2-[(4s,7r)-10-chloro-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-4-yl]acetonitrile

C16H16ClN3 (285.1033)


   

11,16,18-trioxa-4-azapentacyclo[11.7.0.0²,¹⁰.0³,⁷.0¹⁵,¹⁹]icosa-1(20),7,13,15(19)-tetraen-12-one

11,16,18-trioxa-4-azapentacyclo[11.7.0.0²,¹⁰.0³,⁷.0¹⁵,¹⁹]icosa-1(20),7,13,15(19)-tetraen-12-one

C16H15NO4 (285.1001)


   

9-methoxy-8-oxa-17-azatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-1(17),2,4,6,10,15-hexaene-4,14-diol

9-methoxy-8-oxa-17-azatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-1(17),2,4,6,10,15-hexaene-4,14-diol

C16H15NO4 (285.1001)


   

(3s,4s)-3-methoxy-4-phenyl-3h-quinoline-2,4,5-triol

(3s,4s)-3-methoxy-4-phenyl-3h-quinoline-2,4,5-triol

C16H15NO4 (285.1001)


   

5-hydroxy-7-methoxy-3-methyl-2h-cyclohexa[g]isoquinoline-6,9,10-trione

5-hydroxy-7-methoxy-3-methyl-2h-cyclohexa[g]isoquinoline-6,9,10-trione

C15H11NO5 (285.0637)


   

(1r,2s,3s,4s,5r,9s,11s,12s,14r)-7-imino-2-methyl-10,13,15-trioxa-6,8-diazapentacyclo[7.4.1.1³,¹².0⁵,¹¹.0⁵,¹⁴]pentadecane-2,4,12-triol

(1r,2s,3s,4s,5r,9s,11s,12s,14r)-7-imino-2-methyl-10,13,15-trioxa-6,8-diazapentacyclo[7.4.1.1³,¹².0⁵,¹¹.0⁵,¹⁴]pentadecane-2,4,12-triol

C11H15N3O6 (285.0961)


   

4-hydroxy-2,3-dimethoxybenzo[g]quinoline-5,10-dione

4-hydroxy-2,3-dimethoxybenzo[g]quinoline-5,10-dione

C15H11NO5 (285.0637)


   

1,2,3-trimethoxy-10h-acridin-9-one

1,2,3-trimethoxy-10h-acridin-9-one

C16H15NO4 (285.1001)


   

2-({[(5r)-5-hydroxy-2,5-dimethyl-4,6-dioxocyclohex-2-en-1-ylidene]amino}methyl)benzaldehyde

2-({[(5r)-5-hydroxy-2,5-dimethyl-4,6-dioxocyclohex-2-en-1-ylidene]amino}methyl)benzaldehyde

C16H15NO4 (285.1001)


   

3,5-dihydroxy-2,6-dimethyl-7-(2-methyl-1,3-thiazol-4-yl)hept-6-enoic acid

3,5-dihydroxy-2,6-dimethyl-7-(2-methyl-1,3-thiazol-4-yl)hept-6-enoic acid

C13H19NO4S (285.1035)


   

(1r,11s,18r,19s)-5,7,20,21-tetraoxa-14-azahexacyclo[16.2.1.0²,¹⁰.0⁴,⁸.0¹¹,¹⁵.0¹¹,¹⁹]henicosa-2(10),3,8,14-tetraene

(1r,11s,18r,19s)-5,7,20,21-tetraoxa-14-azahexacyclo[16.2.1.0²,¹⁰.0⁴,⁸.0¹¹,¹⁵.0¹¹,¹⁹]henicosa-2(10),3,8,14-tetraene

C16H15NO4 (285.1001)


   

3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4(9),5,7,11,15,17,19-nonaen-14-one

3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4(9),5,7,11,15,17,19-nonaen-14-one

C18H11N3O (285.0902)


   

(3s,4s)-3-methoxy-4-phenyl-3h-quinoline-2,4,6-triol

(3s,4s)-3-methoxy-4-phenyl-3h-quinoline-2,4,6-triol

C16H15NO4 (285.1001)


   

3-methoxy-4-phenyl-3h-quinoline-2,4,5-triol

3-methoxy-4-phenyl-3h-quinoline-2,4,5-triol

C16H15NO4 (285.1001)


   

(2s)-2-amino-4-(3,4-dihydroxy-5-methoxybenzoyloxy)butanoic acid

(2s)-2-amino-4-(3,4-dihydroxy-5-methoxybenzoyloxy)butanoic acid

C12H15NO7 (285.0848)


   

n-{2-[6-(hydroxymethyl)-2h-1,3-benzodioxol-5-yl]phenyl}-n-methylformamide

n-{2-[6-(hydroxymethyl)-2h-1,3-benzodioxol-5-yl]phenyl}-n-methylformamide

C16H15NO4 (285.1001)


   

2,6-dihydroxy-3-methoxy-4-methylbenzo[g]quinoline-5,10-dione

2,6-dihydroxy-3-methoxy-4-methylbenzo[g]quinoline-5,10-dione

C15H11NO5 (285.0637)


   

methyl 2-methoxy-1,5-dioxopyrrolo[1,2-a]quinoline-4-carboxylate

methyl 2-methoxy-1,5-dioxopyrrolo[1,2-a]quinoline-4-carboxylate

C15H11NO5 (285.0637)


   

3,4-dimethoxy-5-methylbenzo[h]quinoline-2,7-diol

3,4-dimethoxy-5-methylbenzo[h]quinoline-2,7-diol

C16H15NO4 (285.1001)


   

7,9-dihydroxy-6-methoxy-3-methylbenzo[g]isoquinoline-5,10-dione

7,9-dihydroxy-6-methoxy-3-methylbenzo[g]isoquinoline-5,10-dione

C15H11NO5 (285.0637)


   

(2s,3s,10r)-11,16,18-trioxa-4-azapentacyclo[11.7.0.0²,¹⁰.0³,⁷.0¹⁵,¹⁹]icosa-1(20),7,13,15(19)-tetraen-12-one

(2s,3s,10r)-11,16,18-trioxa-4-azapentacyclo[11.7.0.0²,¹⁰.0³,⁷.0¹⁵,¹⁹]icosa-1(20),7,13,15(19)-tetraen-12-one

C16H15NO4 (285.1001)


   

3-hydroxy-1,4-dimethoxy-10-methylacridin-9-one

3-hydroxy-1,4-dimethoxy-10-methylacridin-9-one

C16H15NO4 (285.1001)


   

(3r,4s)-4-(4-methoxyphenyl)-3h-quinoline-2,3,4-triol

(3r,4s)-4-(4-methoxyphenyl)-3h-quinoline-2,3,4-triol

C16H15NO4 (285.1001)


   

4,4,9-trimethyl-3,12,14-trioxa-9-azatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-1(17),2(7),5,10,15-pentaen-8-one

4,4,9-trimethyl-3,12,14-trioxa-9-azatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-1(17),2(7),5,10,15-pentaen-8-one

C16H15NO4 (285.1001)


   

2-amino-8-(hydroxymethyl)-3-oxophenoxazine-1-carboximidic acid

2-amino-8-(hydroxymethyl)-3-oxophenoxazine-1-carboximidic acid

C14H11N3O4 (285.075)


   

4-(4-methoxyphenyl)-3h-quinoline-2,3,4-triol

4-(4-methoxyphenyl)-3h-quinoline-2,3,4-triol

C16H15NO4 (285.1001)


   

(3s,4r)-4-(4-methoxyphenyl)-3h-quinoline-2,3,4-triol

(3s,4r)-4-(4-methoxyphenyl)-3h-quinoline-2,3,4-triol

C16H15NO4 (285.1001)


   

5,10-dihydroxy-7-methoxy-3-methylcyclohexa[g]isoquinoline-6,9-dione

5,10-dihydroxy-7-methoxy-3-methylcyclohexa[g]isoquinoline-6,9-dione

C15H11NO5 (285.0637)


   

3,11,21-triazapentacyclo[11.8.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2,4,6,8,13,15,17,19-nonaen-10-one

3,11,21-triazapentacyclo[11.8.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2,4,6,8,13,15,17,19-nonaen-10-one

C18H11N3O (285.0902)


   

4-hydroxy-3,6-dimethoxy-2-methyl-9h-carbazole-1-carbaldehyde

4-hydroxy-3,6-dimethoxy-2-methyl-9h-carbazole-1-carbaldehyde

C16H15NO4 (285.1001)


   

16-methyl-13-(prop-1-en-2-yl)-3,5,14-trioxa-16-azatetracyclo[7.7.0.0²,⁶.0¹¹,¹⁵]hexadeca-1,6,8,11(15)-tetraen-10-one

16-methyl-13-(prop-1-en-2-yl)-3,5,14-trioxa-16-azatetracyclo[7.7.0.0²,⁶.0¹¹,¹⁵]hexadeca-1,6,8,11(15)-tetraen-10-one

C16H15NO4 (285.1001)


   

(2s,3r,5r,6e)-3,5-dihydroxy-2,6-dimethyl-7-(2-methyl-1,3-thiazol-4-yl)hept-6-enoic acid

(2s,3r,5r,6e)-3,5-dihydroxy-2,6-dimethyl-7-(2-methyl-1,3-thiazol-4-yl)hept-6-enoic acid

C13H19NO4S (285.1035)


   

4-[(1z)-2-hydroxyethenyl]phenyl (3z)-3-(hydroxyimino)-4-oxocyclohexa-1,5-diene-1-carboxylate

4-[(1z)-2-hydroxyethenyl]phenyl (3z)-3-(hydroxyimino)-4-oxocyclohexa-1,5-diene-1-carboxylate

C15H11NO5 (285.0637)


   

3-hydroxy-1,2-dimethoxy-10-methylacridin-9-one

3-hydroxy-1,2-dimethoxy-10-methylacridin-9-one

C16H15NO4 (285.1001)


   

4-hydroxy-3-(3-hydroxy-3-methylindol-2-yl)-5,6-dimethylpyran-2-one

4-hydroxy-3-(3-hydroxy-3-methylindol-2-yl)-5,6-dimethylpyran-2-one

C16H15NO4 (285.1001)


   

(3s)-3-hydroxy-3-[(2-hydroxy-4,5-dimethoxyphenyl)-c-hydroxycarbonimidoyl]propanoic acid

(3s)-3-hydroxy-3-[(2-hydroxy-4,5-dimethoxyphenyl)-c-hydroxycarbonimidoyl]propanoic acid

C12H15NO7 (285.0848)


   

2-[(4s)-10-chloro-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-4-yl]acetonitrile

2-[(4s)-10-chloro-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-4-yl]acetonitrile

C16H16ClN3 (285.1033)


   

(3s,4s)-4-(4-methoxyphenyl)-3h-quinoline-2,3,4-triol

(3s,4s)-4-(4-methoxyphenyl)-3h-quinoline-2,3,4-triol

C16H15NO4 (285.1001)


   

(3r,4r)-4-(4-methoxyphenyl)-3h-quinoline-2,3,4-triol

(3r,4r)-4-(4-methoxyphenyl)-3h-quinoline-2,3,4-triol

C16H15NO4 (285.1001)


   

3-hydroxy-3-[(2-hydroxy-4,5-dimethoxyphenyl)-c-hydroxycarbonimidoyl]propanoic acid

3-hydroxy-3-[(2-hydroxy-4,5-dimethoxyphenyl)-c-hydroxycarbonimidoyl]propanoic acid

C12H15NO7 (285.0848)


   

(6e)-3,5-dihydroxy-2,6-dimethyl-7-(2-methyl-1,3-thiazol-4-yl)hept-6-enoic acid

(6e)-3,5-dihydroxy-2,6-dimethyl-7-(2-methyl-1,3-thiazol-4-yl)hept-6-enoic acid

C13H19NO4S (285.1035)


   

4-(2-hydroxyethenyl)phenyl 4-hydroxy-3-nitrosobenzoate

4-(2-hydroxyethenyl)phenyl 4-hydroxy-3-nitrosobenzoate

C15H11NO5 (285.0637)


   

5,7,20,21-tetraoxa-14-azahexacyclo[16.2.1.0²,¹⁰.0⁴,⁸.0¹¹,¹⁵.0¹¹,¹⁹]henicosa-2(10),3,8,14-tetraene

5,7,20,21-tetraoxa-14-azahexacyclo[16.2.1.0²,¹⁰.0⁴,⁸.0¹¹,¹⁵.0¹¹,¹⁹]henicosa-2(10),3,8,14-tetraene

C16H15NO4 (285.1001)


   

2-amino-4-(3,4-dihydroxy-5-methoxybenzoyloxy)butanoic acid

2-amino-4-(3,4-dihydroxy-5-methoxybenzoyloxy)butanoic acid

C12H15NO7 (285.0848)